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Redox regulation and homeostasis are critically important in the regulation of cell 
function; however, there are significant challenges in quantitatively measuring and 
monitoring intracellular redox potentials.  
 
The work in this thesis details a novel approach to intracellular redox monitoring. 
The approach is based on the use of nanosensors, which comprise molecules capable 
of sensing the local redox potential, assembled on gold nanoshells. Since the Raman 
spectra of the sensor molecules change depending on their oxidation state, and since 
the nanoshells allow a large enhancement of the Raman scattering, intracellular 
potential can be calculated by simple optical measurements. A full description of the 
design, fabrication and characterisation (spectroscopic and electrochemical) of the 
nanosensors is provided within.   
 
The ability to deliver nanosensors into cells in a controllable fashion was confirmed 
using electron microscopy. Results from a range of assays are also presented which 
reveal that introduction of nanosensors does not result in any cytotoxicity. 
 
Sensor utility in monitoring redox potentials as cells responded to physiological and 
superphysiological oxidative and reductive stimuli was investigated. Importantly, the 
capability of the nanosensors in monitoring intracellular potentials in a reversible, 
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In cells, redox potential (RP) is a highly regulated and compartmentalised property. 
Its homeostasis and regulation are critical in numerous cellular processes and events 
including: cell cycle, differentiation, apoptosis, inflammation, toxicity, protein 
interactions and signalling.
1,2,3,4,5
 Despite its importance, the study of intracellular 
redox potential (IRP) has thus far been limited by the lack of suitable techniques with 




Figure 1.1: Variation of IRP through different biological stages of the cell cycle. In 
healthy cells, potential (E) is most negative during proliferation.
6
 As E increases, 
cells may undergo differentiation, or apoptosis (programmed cell death).
6
 Extremely 
high values of E from oxidative stress will eventually result in necrosis.
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An ideal system for IRP measurements should be able to: 
 
(1) Quantitatively and reversibly monitor potential in live cells, with good 
spatiotemporal resolution. 
 
Many traditional methods of calculating IRP involve cell lysis and cumbersome 
analytical separations.
7
 Sensors would preferably be able to monitor, in real-time, 
potential from discrete cellular locations. 
  
(2) Monitor RP with sub-cellular resolution. 
 
It has been shown that the RPs of organelles are not in equilibrium with each other. 
For instance, the endoplasmic reticulum (ER) is held at a more oxidative poise than 
the cytoplasm in order to facilitate protein folding.
8
 On the other hand, the nucleus 
may be held at a more reductive poise
6
 in order to protect important biomolecules 
such as deoxyribonucleic acid (DNA) from oxidative damage.
9
 The ability to target, 
efficiently and effectively, a sensor to monitor the potential in specific organelles 
would offer better understanding of cellular redox processes and how IRP is 
modulated throughout the life cycle of a cell. 
 
(3)  Monitor RP over a wide range covering hypoxic conditions, through the 
processes involved in oxidative stress. 
 
The hypothetical electrochemical window of a cell spans more than a volt (as 
determined by reduced nicotinamide adenine dinucleotide phosphate (NADPH) 
(most reducing redox couple) and oxygen (most oxidative redox couple).
6
 The 
current state of the art redox sensors possess relatively low mid-point potentials and, 
therefore, cannot accurately report on potentials in more oxidising environments, or 
during oxidative processes.
10,11,12
 Widening the current range of intracellular 
potential measurements would thus prove highly advantageous when monitoring the 
potential inside oxidative compartments such as the ER or lysosomes,
8,13
 or when 
following potential changes through processes such as apoptosis or necrosis. 
3 
 
(4) Be non-perturbing to the native redox poise of the cell. 
 
The delivery of any system designed to probe the redox environment of a cell should 
not result in any reductive or oxidative toxic side effects. 
 
1.2 Regulation of Intracellular Redox Potential 
 
RP can be defined as: 
 
‘The reducing or oxidising power of a system, measured against the potential 
at a hydrogen electrode.’ 
         -Biology Online 
 
Developed in 1889 by Walter Nernst, his famous equation allows comparison of 
potentials measured under standard conditions (E
ө















Equation 1.1: The Nernst equation (assuming equilibrium). Where E = potential 
(V), E
ө
 = standard potential (V); R = universal gas constant; T = temperature (K); F 
= Faraday’s constant; n = number of electrons involved in transfer reaction; [O] = 
concentration of oxidised species; and [R] = concentration of reduced species. 
 
The Nernst equation has particular importance in biology, where electron transfer 
reactions are common-place.
6
 Indeed, many of the current methods used to measure 
or monitor IRP rely on the Nernst equation.  
         
4 
 
IRP can be thought of as a delicately balanced cellular property. It relies on a variety 
of factors including, on the one hand, reactive oxygen species (ROS), and on the 
other hand, the cell’s antioxidant system (including glutathione (GSH), thioredoxin, 
NADPH and enzymes) which detoxifies them.  
 
1.2.1 ROS and Oxidative Stress 
 
ROS are highly reactive oxygen-containing molecules. Examples of prominent 
cellular ROS include: hydrogen peroxide (H2O2), superoxide (O2
·-
), hydroxyl radicals 
(
∙






With a concentration of 10
-7
 M and a half-life (t1/2) of 10
-5
 s, H2O2 is by far the most 
abundant and most stable intracellular ROS.
2
 H2O2 is generated mainly as a result of 
electron leakage from the mitochondrial electron transport chain (ETC).
2,16
 In the 
ETC, electrons are transported across four protein complexes to molecular oxygen, 
generating water and establishing a proton gradient across the inner mitochondrial 
membrane.
16,17
 Energy from this gradient is then used to drive production of 
adenosine triphosphate (ATP), which is a cell’s primary source of energy.
17
 
However, this process is not 100% efficient and electrons can leak from the ETC. 




 This is the 
main source of intracellular oxidant. Aided by superoxide dismutase (SOD) 
enzymes, O2
·- 
can be dismutated to H2O2 and O2.
2,16
 H2O2 can be decomposed by 
catalase (CAT) to form water and molecular oxygen,
18





 Due to their high reactivity with biomolecules, 
∙
OH are considered to 
be among the most hazardous ROS.
20
 Despite the cytotoxic effects it can cause, it is 
worth noting that H2O2 has also been shown to be an important cell-signalling 
molecule in a variety of processes.
1,2
    
 





























Figure 1.2: Mitochondrial ROS generation. Electron leakage from the ETC can lead 
to O2
·- 
formation. SOD enzymes convert the O2
·- 
into H2O2 which can translocate 
from the mitochondria to the cytoplasm and be converted into water and oxygen by 
catalase or participate in intracellular Fenton reactions.   
 
Synthesised enzymatically by NO synthase (NOS) from L-arginine,
21
 NO is also an 
important cellular ROS. Inside cells, NO can react with O2
·- 
forming highly cytotoxic 
peroxynitrite.
15
 NO can also react with GSH to form S-nitrosoglutathione (GSNO), 
which can act as a NO reservoir/donor.
22
 Like H2O2, NO is also an important cell-
signalling molecule, particularly affecting the vascular system.
23
 Figure 1.3 below 
shows how NO is synthesised in cells and the fates which may befall it.   
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Figure 1.3: NO synthesis form L-arginine by NOS and possible intracellular fates of 
NO including: reaction with GSH, formation of peroxynitrite (leading to biomolecule 
damage) and effects on the vascular system (particularly in vasodilatation).  
 
Although ROS are produced endogenously by cells and are important biological 
messengers and cell-signalling molecules, their unrestricted generation can lead to 





Oxidative stress can be defined as an increase in oxidant generation that cannot be 
sufficiently dealt with by a cell’s antioxidant defence mechanisms. 
 

































Figure 1.4: Mechanism showing how oxidative stress can be imposed on cells. Cell 
damage is induced by ROS. The main source of ROS in vivo is aerobic respiration, 
although ROS are also produced by other means including cytochrome P450 
metabolism of xenobiotic compounds. Under normal conditions, ROS are cleared 
from the cell by the action of SOD, catalase, or glutathione peroxidase. The main 
damage to cells results from the ROS-induced alteration of macromolecules such as 
polyunsaturated fatty acids in membrane lipids, essential proteins, and DNA. 
   
As mentioned on page 4, O2
·-
 radicals in cells are generated mainly from the reaction 




 can react with 




 or are dismutated by SOD to form 
H2O2.
2,16







 It may also be degraded by CAT (to water and oxygen) 
or through the glutathione peroxidase (GPx) system (to water).
22
 There are other 
intracellular sources of ROS, including those that come from the breakdown of 






Under normal physiological conditions, these ROS are eliminated from the cell by its 
antioxidant defence systems. Oxidative stress ensues if ROS generation exceeds the 
capabilities of the cell’s antioxidant defence system,
6,24
 or if there is malfunction 
within the antioxidant defence system. The ROS generated during oxidative stress 
can go on to cause major damage to critical biomolecules, such as nucleic acids, 
lipids or proteins.
6,24,25
 At a molecular level, common damages caused to these 
biomolecules by ROS include: hydroxylation of DNA bases, peroxidation of lipids, 
tyrosine nitration and cysteine oxidation (figure 1.5).
27,28,29
 Indeed, the onset of 
oxidative stress has been implicated in several disease states including: cancers, 






Figure 1.5: Common biomolecule damage caused by ROS. Top left – 8-
hydroxyguanine. Top right – an unsaturated, peroxidised lipid. Bottom left – nitrated 











1.2.2 Antioxidant Defences 
 
In order to defend themselves and detoxify ROS, cells harbour several important 
antioxidant defence mechanisms. These systems are crucial in the protection of 




Glutathione (GSH) is a tripeptide, synthesised naturally in the body from the amino 
acids (AAs) L-cysteine, L-glutamic acid, and glycine.
22
 With concentrations ranging 
from 1-10 mM in the cytoplasm, GSH is considered to be the major thiol-disulfide 
redox buffer/antioxidant defence of the cell.
6
 In cells, GSH can become oxidised to 
form glutathione disulfide (GSSG). The structures of GSH and GSSG are shown 
below in figure 1.6. In cells, under normoxic conditions, more than 90% of total 
glutathione exists as GSH.
6
 Any increase in the [GSSG]:[GSH] ratio is generally 








































Figure 1.7: Defence actions of GSH. Synthesised from glutamic acid, cysteine and 
glycine GSH can detoxify ROS (such as H2O2) through the GPx system. It can also 
detoxify harmful xenobiotic substances through the GST system and helps to 
maintain a steady concentration of ascorbic acid through the GR system. 
 
As an antitoxic agent, GSH is able to act as both a nucleophile and as a reductant. It 
can react with harmful electrophilic or oxidising xenobiotic species and prevent them 
from reacting with and causing damage to important biomolecules.
22,25
 
Detoxifications involving GSH are catalysed by glutathione S-transferases (GSTs),
22 




Arguably, GSH’s most important defence function is that of an antioxidant. Just as 
GSH is able to detoxify harmful xenobiotics, it can also neutralise ROS like H2O2 
through the GPx system.
22
 Again, this helps to prevent crucial biomolecules suffering 
oxidative damage. GSH also participates in the glutathione-ascorbate metabolic 
pathway, whereby GSH-dependent dehydroascorbate reductases (DHARs) help 
sustain a steady concentration of ascorbic acid (vitamin C) in the face of oxidative 
stress.
22
 GSH is regenerated from these processes through glutathione reductase (GR) 
which catalyses the reaction of GSSG with NADPH to yield GSH along with 









The thioredoxin system is another crucial thiol-disulfide antioxidant system present 
in micromolar concentration in cells. Thioredoxins are large oxidoreductase proteins 






Figure 1.8: Crystal structure of thioredoxin showing (A) an overview of the 
secondary structure of barley thioredoxin h (HvTrxh2) in a disulfide linked complex 




Thioredoxins exert their antioxidant effect by facilitating protein reduction through 
cysteine thiol-disulfide exchange.
24
 Unlike GSH which forms inter-molecular 
disulfides, thioredoxins usually form intra-molecular disulfides which can be reduced 







Figure 1.9: Antioxidant mechanism of thioredoxin. Thioredoxin reduces disulfide 
bonds in target proteins. Oxidized thioredoxin is reduced by thioredoxin reductase, 
which receives reducing equivalents from NADPH. 
12 
 
In terms of biological function, by acting as a cytokine modulator, thioredoxins are 
an important part of the inflammatory response.
35,36
 They also facilitate refolding of 




1.2.2.3 Nicotinamide Adenine Dinucleotide Phosphate 
 
NADPH is mainly generated during the oxidative phase of the pentose phosphate 
pathway.
17
 NADPH can provide reducing equivalents for the redox processes 
involved in the detoxification of ROS.
22,24,25
 It is responsible for reconversion of 
GSSG and oxidised thioredoxin (Trx-S2) to their reduced states. The NADPH system 
also generates free radicals for immune cells to destroy pathogens in the respiratory 
burst.
38
 Figure 1.10 below shows the structure of NADP
+
, along with its reduction to 




Figure 1.10: Structure of NADP
+
 along with its reduction reaction during which it 




1.2.2.4 Antioxidant Enzymes 
 
Enzymes are globular proteins that catalyse biological processes.
17
 In cells, enzymes 
are an important part of the antioxidant defence system and work in conjunction with 
small molecules like GSH and NADPH, as well as thioredoxin, to protect cells 




SODs were among the first antioxidant enzymes to be discovered.
40
 Highly efficient 
in their function, SODs operate by converting O2
·-







Figure 1.11: Dismutation of O2
·-
 by SOD to form H2O2 and oxygen.  
 
Through intracellular Fenton reactions, 
∙
OH can be formed from H2O2.
19,41 
CAT 
lowers the risk of this occurring, by catalysing the dismutation of H2O2 into water 






Figure 1.12: Dismutation of H2O2 by CAT to form water and oxygen. 
 
Both the GSH and thioredoxin systems have several important associated enzymes 
that ensure their optimum function. GPxs catalyse reactions which detoxify ROS 
(figures 1.4 and 1.6).
22,25
 GSH and thioredoxin reductases ensure that GSSG and 









1.2.2.5 ROS Regulation of Gene Expression and Cellular Control of Free 
Transition Metals 
 
While the harmful effects of excessive ROS generation/accumulation in cells have 
been discussed it is also important to take into account that they play important roles 
as cellular messengers.
2
 One of the most important functions of ROS is the 
regulation of gene expression.
2,42,43
 Many cellular proteins possess cysteine residues, 
which can be subjected to oxidation/reduction reactions at their thiol moieties.
2,42
 
Indeed, H2O2 has been shown to regulate the activity of a host of kinases and 
phosphatases through oxidation.
2,42
 Some of these proteins are in fact transcription 
factors (proteins that control the flow of genetic information from DNA to RNA). 
The transcription factor AP-1 is one of the most studied cases of transcriptional 
redox regulation. Through induction by H2O2 AP-1 can control the regulation of a 
number of genes involved in the cellular processes of differentiation, proliferation 
and apoptosis.
42
 Other important transcription factors regulated by ROS include 
MTF-1 (which is involved in metal homeostasis) and NF-KB (which is involved in 




Traces of transition metals such as iron, copper, manganese and zinc are commonly 
found within our cells and are essential in their healthy function.
17
 As outlined in 
section 1.2.1, free transition metals in cells can participate in harmful intracellular 
Fenton reactions which can lead to ROS generation and subsequent biomolecule 
damage. It would, however, be inaccurate to suggest that the presence of free 
transition metals in cells is widespread and unchecked. While increased cellular 
levels of transition metals have been associated with neurological diseases,
31
 in 
healthy cells transition metals are tightly regulated.
44,45,46
 For example, iron, an 
important component of haemoglobin and a variety of redox enzymes, has its uptake 
regulated by a number of proteins including transferrin and iron regulatory 
proteins.
44
 Similarly, zinc, important as a co-factor and intracellular mediator, is 
regulated by proteins which control its uptake and intracellular trafficking. These 






1.3 Current Techniques for Measuring and Monitoring 
Intracellular Redox Potential 
 
There are several techniques available for the study of IRP. While each has its 
merits, none of them currently meet the requirements for an ideal cellular redox 
monitoring system, as outlined on page 2. 
 
One of the common drawbacks of current techniques used in IRP measurement is 
tailoring them to measure cellular GSH. While it has been widely acknowledged as 
the main thiol-disulfide redox buffer of the cell,
6
 the other systems described on 
pages 11-14 also play important roles. In the dynamic environment of a cell, where 
redox couples are not necessarily in equilibrium with one another, there is no one 
fixed IRP value. IRP will vary depending on the particular redox couple being 
measured, the relative concentrations of redox couples and where exactly in the cell a 
measurement is being taken from.
6
 For example, the NADPH/NADP
+
 redox couple 
has an E°’ of -315 mV whereas the E°’ of GSH/GSSG is more oxidising at -240 mV 
(both vs. NHE at pH 7).
6
 Moreover, while, for instance, the cytoplasm has been 
shown to possess relatively reducing redox potentials (approximately -270 mV) the 
ER has been shown to possess a considerably more oxidising redox potential 
(approximately -209 mV).
6,8
 Therefore, one cannot simply give a definitive value of 
IRP based solely on the measurement of a single redox couple or from a single 
organelle.  
 




 developed an enzymatic assay for the quantification of cellular 
glutathione. The assay uses enzymatic recycling, with GR employed, in order to 
ensure reduction of all cellular glutathione to GSH. The thiol groups of GSH are then 
allowed to react with DTNB. This produces 5-thio-2-nitrobenzoic acid (TNB) 
(yellow in colour) and a complex glutathione-S-5-thio-2-nitrobenzoic acid (GSTNB). 
The GSTNB complex is reduced by GR to regenerate GSH and more TNB. The rate 
16 
 
of TNB formation is directly proportional to the GSH concentration in the sample, 






Figure 1.13: Schematic of the GSH-recycling assay. After converting all cellular to 
GSSG with GR, thiol groups of GSH can react with DTNB producing GSTNB and 
TNB. GSTNB is reduced by GR to regenerate GSH and produces more TNB. TNB 
formation rate is directly proportional to sample GSH concentration.  
 
In order to determine GSSG levels, GSH must first be derivatised. This prevents 
GSH from taking part in the cycle shown in figure 1.13, to allow sole determination 
of GSSG. Initially, N-ethylmaleimide (NEM) was employed by Tietze
47
 as a thiol 
masking agent for GSH. Lack of specificity and the need to eliminate excess NEM, 
which could potentially inhibit GR, made the technique somewhat error-prone and 
time-consuming.
48
 However, the replacement of NEM with 1-methyl-2-vinyl-
pyridinium trifluoromethane sulfonate (M2VP), or 1-methyl-4-vinyl-pyridinium 
trifluoromethane sulfonate (M4VP), as derivatisation agents, enabled Tietze’s assay 




Once total GSH and GSSG concentrations have been determined, the [GSH]:[GSSG] 
ratio can be calculated. Usually, GSH and GSSG concentrations are expressed in 
molar concentrations and quoted against the total protein content of cells (usually 
reported in mg). These ratios can then be input to the Nernst equation, from which a 
value of cellular RP can be estimated. RP values of mammalian cells have been 
reported between -315 and -280 mV vs. NHE.
50
 [GSH]:[GSSG] ratios outside the 
17 
 
homeostatic will result in potential values outside this range and serve as an indicator 
of cellular toxicity.  
 
Tietze’s assay is still widely in use today. While the assay is relatively simple to 
perform and gives the user a useful indication of toxicity, it suffers from some 
significant drawbacks. The assay cannot be used for live cellular RP monitoring, as it 
requires the harvesting of GSH from cells. In order to achieve this, cells have to be 
lysed.
47
 Moreover neither inter- nor intra-cellular potential variation can be 
accounted for, as GSH is harvested indiscriminately from populations consisting of 
thousands of cells. The assay is also prone to inaccuracy resulting from the oxidation 
of GSH to GSSG in air.
48,49
 Therefore, users must be extremely careful in sampling 
and sample handling.   
 
1.3.2 High Performance Liquid Chromatography (HPLC) 
 
Detection and quantification of GSH and GSSG by HPLC has also been extensively 
demonstrated. As may be expected, these two molecules can be easily separated on a 
column (mostly, reverse-phase HPLC (RP-HPLC) is used).
7
 Indeed, characteristic 
retention times allow their resolution in complex biological samples which contain a 
variety of other species. Key advantages of using HPLC over the GSH recycling 
assay include higher sensitivity and simultaneous detection of GSH and GSSG. 




Unfortunately, using HPLC to measure the GSH:GSSG ratio suffers from all the 
drawbacks associated with the earlier GSH recycling assay. Cell lysis is still required 
and, therefore, the technique is unsuitable for monitoring. Neither organelle nor cell-
to-cell variation can be accounted for and oxidation of GSH in air is still a concern to 







1.3.3 Hydrocyanine Dyes 
 
Developed in 2009 by Kundu et al,
52
 hydrocyanines are a membrane-permeable 
family of ROS sensors. They can be easily synthesised from the reduction of 






Figure 1.14: Synthesis of non-fluorescent hydro-Cy3 by a one-step reduction with 
NaBH4. Reaction with ROS oxidises hydro-Cy3 to generate fluorescent Cy3. 
     
These compounds offer significant advantages over other fluorescent ROS sensing 
dyes. They display excellent stability to autoxidation, tuneable emission 
wavelengths, and nanomolar sensitivity to ROS.
52
 Despite this, hydrocyanines (and 
other fluorescent dyes) cannot be employed to report on the RP of the cell – only on 
the rate of formation of particular ROS. Since they operate via covalent reaction (i.e. 
they are non-reversible), they are unsuitable for monitoring. Furthermore, they do not 
take into account the mechanisms that the cell naturally puts into place for 
detoxification of ROS (e.g. in the presence of an efficient antioxidant system, a rise 
in ROS may not dramatically impact the redox state of the cell). 
19 
 
1.3.4 Glutathione Reductase Crystals 
 
In 1999, Keese et al reported using crystals of GR to monitor the RP in the 
cytoplasm of human fibroblasts.
53
 When oxidised, the crystals appear yellow, but 
upon exposure to solutions containing GSH or NADPH (reductants), they become 
orange-red (figure 1.15). In their reduced state, GR crystals have a free thiol at Cys-
58 and a free thiolate at Cys-63. The free thiolate can form a charge transfer (CT) 
complex with flavin.
53
 Formation of this CT complex is accompanied by the rise of a 






Figure 1.15: Colour changes of GR crystals. An oxidised (yellow) GR crystal is 
shown on the left and a reduced (orange-red) GR crystal is shown on the right.
53  
 
Keese et al micro-injected the crystals into the cytoplasm and reported on the RP 
through colour changes in the crystals (figure 1.15).
53
 Unlike the GSH recycling 
assay or HPLC, these crystals offer the chance to monitor RP from inside live cells 
on a single cell basis. This technique is, however, cumbersome and suffers from slow 






1.3.5 Redox-Active Green Fluorescent Proteins  
 
First isolated from the jellyfish Aequorea Victoria, GFP
54
 has been a revelation in 
fluorescence imaging and cell biology. Its importance was perhaps best highlighted 
in 2008, when Martin Chalfie, Osamu Shimomura, and Roger Y. Tsien were 




In 2004, GFPs with engineered cysteines introduced into their beta-barrel structures 
(figure 1.16), so-called redox-active GFPs (roGFPs), were presented as a novel tool 






Figure 1.16: Crystal structures showing (A) the β-barrell secondary structure of 




roGFPs possess two fluorescence excitation maxima at around 400 and 490 nm.
10,11
 
These maxima display ratiometric changes in fluorescence intensity depending on 
the oxidation state(s) of the engineered cysteine residues (figure 1.17). This ratio can 









Figure 1.17: Excitation spectra for fully oxidized and reduced (A) roGFP1 and (B) 
roGFP2. Emission was monitored at 515 nm. (C) Titration of roGFP1 (1 μM) with 
dihydrolipoate + lipoate buffers (total 10 mM) and (D) titration of roGFP2 (1 μM) 




Regarding monitoring IRP, roGFPs are the current ‘gold standard’. They are non-
toxic, accurate and can monitor RP changes reversibly and in real-time from single 
cells.
12
 Despite their obvious benefits, roGFPs have limitations. Measurements can 
only be made in a narrow potential window (roGFPs have standard reduction 
potentials between -290 and -230 mV vs. NHE)
10,11,12
 and they have been 
demonstrated to be insufficiently stable to oxidation to measure the potential of ER 
or endosomal compartments and are, therefore, unlikely to be useful for studies of 
oxidative stress.
12 
Furthermore, protein engineering offers little scope for useful 
modification of these molecules for extension to wider potential ranges. 
22 
 
While it may be the cell’s main redox governor, GSH is not the only molecular 
system that it harbours to modulate RP and maintain homeostasis. In order to report 
an overall ‘global’ IRP value, the other systems outlined on pages 10-11 should also 
be accounted for. Indeed, roGFPs (and many of the other techniques described in 
section 1.3) are specific for GSH and fail to consider the contributions of the other 
systems to IRP.    
 
1.4 An Alternative Approach to Intracellular Redox 
Monitoring  
 
With regard to live cellular imaging, fluorescence has long been the dominant 
spectroscopic technique used in academia and industry. While it is a well established 
and highly sensitive analytical technique, it does have several disadvantages when 
applied to cellular studies. For instance, molecules have to be ‘tagged’ with 
fluorophores which may be susceptible to photo-bleaching.
56
 Often, fluorescence is 
limited to the visible region of light, where cells absorb and may be damaged.
57,58
 
Specificity is also an issue; broad spectral fluorescence can be prone to error caused 
by spurious background signals.
59





Surface enhanced Raman spectroscopy (SERS) offers an attractive and viable 
alternative to fluorescence in live cellular studies. 
 
1.4.1 Raman Spectroscopy 
 
In 1928, two Indian scientists, C.V. Raman and K.S. Krishnan reported the inelastic 
scattering of light.
60






Figure 1.18: Energy level diagram showing the Rayleigh and Raman scattering 
processes. In Rayleigh or elastic scattering (red line), re-radiated photons possess the 
same energy as incident photons. In Raman or inelastic scattering, however, there is 
a shift in energy. Stokes scattering (blue line) results in photons being re-radiated 
with less energy while anti-Stokes scattering sees re-radiated photons gain energy.  
 
In scattering, photons interact with a molecule’s electron cloud around the nuclei, 
distorting it and leading to the formation of a short-lived ‘virtual state’. These so 
called ‘virtual states’ are, however, unstable and photons are quickly re-radiated. The 
majority of re-radiated photons have the same energy as the incident photons 
interacting with the molecule. This type of scattering is known as elastic or Rayleigh 
scattering and is by far the most dominant form of light scattering. When energy is 
transferred between the molecule and the photon, an energy difference is created 
between the incident and re-radiated photons. This is inelastic or Raman scattering. 
In Raman scattering, energy can be transferred from the incident photon to the 
molecule, resulting in Stokes scattering, which is the strongest form of Raman 
scattering. Stokes scattered photons are emitted at a lower energy than the incident 
photons. The difference in energy according to Boltzmann’s distribution means that 
some molecules may be present in an excited vibrational state; it is, therefore, 
possible for the energy of the excited state to transfer to the scattered photon. Anti-



















Raman spectroscopy, it is the shift in vibrational frequency (and energy) of the 




While Raman spectroscopy is similar to infrared (IR) spectroscopy, in that they both 
report on a molecule’s vibrational frequencies, there are some key differences 
between the two. In order for a vibration to be Raman active, analytes must undergo 
a change in polarisability. In Raman spectroscopy, symmetric vibrations are 
strongest. For a vibration to be IR active, analytes must undergo a change in dipole 




IR is a long-established analytical technique. With cheaper and simpler 
instrumentation, it may seem more attractive than Raman as a vibrational 
spectroscopy. However, Raman spectroscopy offers users numerous key advantages 
over IR spectroscopy. Minimal sample preparation is required for Raman analysis 
and fingerprint spectra of analytes can be obtained in seconds. Raman spectroscopy 
can also be used for remote sampling and allows samples to be analysed in glass or 
polymer packaging. It is relatively insensitive to water, making it ideal for biological 
analyses. Also, as it grows in popularity, cheaper high-performance, Raman 




Arguably, the main disadvantage of Raman spectroscopy is the fact that the Raman 
effect is weak. Roughly, only 1 in 10 million photons that are scattered by molecules 
are actually Raman scattered (the vast majority are elastically scattered).
61
 
Fortunately, the Raman effect can be enhanced.   
 
1.4.2 Surface Enhanced Raman Scattering  
 
SERS was first reported in 1974 by Fleischmann et al,
62
 when they curiously 
observed an enhancement of Raman signal from pyridine molecules adsorbed on a 
roughened silver surface. Since then, enhancements of Raman signal on the order of 
10
14
 have been claimed with SERS
63
 and its popularity has been steadily growing 




As suggested by the name, SERS is a surface-sensitive technique. Enhancement of 
Raman signal occurs when analytes are in close proximity with a metal surface (most 
commonly, silver or gold nanoparticles), which provides a localised surface plasmon 
resonance (SPR). SPR occurs when a metal nano-structure has its surface electrons 
excited by light with a wavelength corresponding to the resonance frequency of the 




The exact mechanics of how SERS takes place is still a matter of debate in the 
literature. However, there are two generally accepted theories as to how SERS 
occurs: electromagnetic enhancement and chemical enhancement. 
 
(1) Electromagnetic enhancement – This theory describes an interaction between 
analytes adsorbed or held close to the metal surface and surface plasmons. Concisely, 
it describes an increase in the local electric field (equation 1.2) provided by the 
surface and experienced by the analyte.
61  
 




) E0 cos Θ 
 
Equation 1.2: Description of the electric field at the surface of a metal sphere. 
Where: Er is the total electric field at a distance r from the sphere; a is the radius of 
the sphere; Θ is the angle relative to the direction of the electric field; and g is a 
constant (related to the dielectric constants). 
 
In order for a molecule to experience an increase in polarisability, and thus Raman 
cross-section, it has to be orientated perpendicular to the metal surface.
61
 It has also 
been shown that, while SERS can be observed from single nanoparticles,
63
 greater 
enhancements are obtained from the junctions between particles in aggregates, where 




(2) Chemical enhancement – This theory involves CT between the analyte and 
metal surface. Through chemical bond formation electrons and holes can be 
26 
 
transferred from the metal into the analyte. This serves to increase the polarisability 




Owing to its high sensitivity, relative simplicity, insensitivity to water and potential 
for multi-plexing, it has been demonstrated that SERS is a viable alternative to 




1.4.3 Gold Nanoshells 
 
Today, colloidal suspensions of gold nanoparticles ranging in size from ~5-100 nm 
are among the most common SERS substrates. While these can and have been used 
for intracellular SERS experiments there is now an alternative class of gold 
nanoparticle (gold nanoshells) which offers several distinct advantages over colloidal 
gold. Gold nanoshells (NS) are a class of tuneable gold nanoparticle, comprising a 
dielectric core (silica) surrounded by a thin metallic (gold) shell.
67
 NS are ideal 
substrates for intracellular SERS measurements, because they exhibit a strong, 
tuneable plasmon resonance in the near IR region (where cells absorb poorly) and 
exhibit low auto-fluorescence (figure 1.19).
68
 It is well known that, regarding SERS 
from colloidal gold nanoparticles, enhancements in Raman scattering are greater 
when the particles are aggregated and there is overlap of the surface plasmons.
64
 
Plasmon overlap creates an enhanced electric field and leads to formation of local 
‘hot spots’.
64
 With the hybridisation of the core and shell plasmons, NS are known to 
generate stronger SERS signals, compared to unaggregated homogenous 
nanoparticles.
 
Additionally, it has been demonstrated that NS can be controllably 









Figure 1.19: NS and their tuneable plasmon resonances. By varying the core:shell 
ratio the wavelength of the plasmon resonance can be tuned. Increasing the core:shell 





1.5 Project Aims 
 
The main aims of the project were: 
 
(1) To design and characterise nanosensors with SERS fingerprints that are 
sensitive to changes in oxidation state. 
 
Inspired by the previous work of Bishnoi et al, who demonstrated that pH changes 
could be accurately monitored through the SERS spectra of para-mercaptobenzoic 
acid (pMBA),
70
 a range of probe molecules whose SERS spectra were expected to 
change with potential had to be synthesised and assembled on gold nanoparticles. A 
series of spectroelectrochemical proof of concept experiments also had to be 







(2)  To investigate the controlled delivery and toxicity of nanosensors. 
 
Previous studies by the Campbell group, showing the unrestricted endocytotic uptake 
of nanoparticles by cells, were built upon.
71
 It was important to establish that the 
introduction of nanosensors would not produce any toxic side-effects which might 
adversely affect IRP. Targeted delivery of nanoparticles to nuclei was also 
investigated. 
 
(3)  To monitor IRP changes inside cells from discrete locations in real-time. 
 
This was the ultimate goal of the research. The ability of these nanosensors to 
monitor RP changes inside cells, as they responded to super-physiological stimuli 





Materials and Methods 
 
All chemicals and reagents, unless otherwise stated, were purchased from Sigma 
Aldrich and used without further purification. Solvents were purchased from Fisher 
Scientific. 
 
2.1  Synthetic Work 
 
2.1.1  Probe Molecule Synthesis 
 
All nuclear magnetic resonance (NMR) spectra were recorded using a Bruker AVA 
500 MHz spectrometer and analysed with MestReC v4.5.2 software. 
 
All melting points were recorded using Gallenkamp capillary tube melting point 
apparatus.  
 
Analytical thin layer chromatography (TLC) was performed on pre-coated silica 
TLC plates (0.25 mm thickness). Dry-flash column chromatography was carried out 
on silica gel (grade 60, 230-400 mesh, 60 Å). TLC plates and silica gel were 











2.1.1.1 Bis-(2-Anthraquinone carboxamide) (AQ) 
 
 
Scheme 2.1: Synthesis of AQ. Anthraquinone-2-carbonyl chloride is first made from 
anthraquinone-2-carboxylic acid and is subsequently reacted with cystamine to yield 
the product AQ. 
 
126 mg of AQ were synthesised in 50% yield according to the procedure outlined by 
Nagata et al:
72
 mp 219-221 ºC; 
1
H NMR (500 MHz, CDCl3) δH  3.13-3.16 (t, 
3
J 6.3, 
4H), 3.92-3.97 (q, 
3
J 6.3, 4H), 7.41 (b s, 2H), 7.78-7.82 (m, 4H), 8.22-8.37 (m, 8H), 
8.62 (s, 2H); 
13
C NMR (500 MHz, CDCl3) δC 37.98, 39.90, 125.29, 127.33, 127.36, 






Scheme 2.2: Synthesis of NQ via a substitution reaction of 2,3-dichloro-1,4-
naphthoquinone with cystamine. 
 
582 mg of NQ were synthesised in 82% yield according to the procedure outlined by 
Nagata et al:
72
 mp 193-195 ºC; 
1
H NMR (500 MHz, CDCl3) δH 3.02-3.05 (t, 
3
J 6.5, 
4H), 4.21-4.25 (q, 
3
J 6.5, 4H), 6.34-6.43 (b s, 2H), 7.64-7.78 (m, 4H), 8.06-8.18 (m, 
4H); 
13
C NMR (500 MHz, CDCl3) δC  38.64, 43.12, 126.09, 126.98, 129.76, 132.53, 




2.1.1.3  2-Mercaptohydroquinone (HQ) 
 
 
Scheme 2.3: Synthesis of HQ. Sodium thiosulfate is first added to benzoquinone 
before the intermediate is reduced to form the product HQ. 
 
247 mg of HQ were synthesised in 32% yield according to the procedure outlined by 
Monks et al:
73
 mp 112-114 ºC; 
1
H NMR (500 MHz, CDCl3) δH 3.12 (s, 1H), 4.67 (s, 
1H), 5.73 (s, 1H), 6.69-6.96 (m, 3H); 
13
C NMR (500 MHz, CDCl3) δC 113.09, 
115.73, 117.19, 121.10, 149.01, 149.84.   
 
2.1.1.4  N-(2-mercaptoethyl) ferrocene carboxamide (FCBX) 
 
Scheme 2.4: Synthesis of FCBX. Fluorocarbonyl ferrocene is first made from 
ferrocene carboxylic acid and is subsequently reacted with cystamine to yield the 
product FCBX.   
 
202 mg of FCBX were synthesised in 77% yield according to the procedure outlined 
by Schön et al:
74
 mp 207 ºC; 
1
H NMR (500 MHz, CDCl3) δH 1.26 (b s, 1H), 2.99-
3.01 (t, 
3
J 6.3, 2H), 3.72-3.74 (t, 
3
J 6.3, 2H), 4.26 (s, 5H), 4.38-4.40 (m, 2H), 4.79-
4.81 (m, 2H), 6.95 (b s, 1H); 
13
C NMR (500 MHz, CDCl3) δC 35.21, 41.89, 72.15, 




453 mg of fluorocarbonyl ferrocene were synthesised as an intermediate in 78% 




H NMR (500 MHz, 
CDCl3) δH 4.25 (s, 5H), 4.50-4.52 (m, 2H), 4.78-4.80 (m, 2H).  
 
2.1.2 Nuclear Localisation Sequence (NLS) Peptide Synthesis 
 
9-fluorenylmethyloxycarbonyl (Fmoc)-protected AAs, Rink amide linker and 2-(1H-
Benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) were 
purchased from GL Biochem.  
 
Peptide purity was assessed by HPLC, using an Agilent 1100 series HPLC coupled 
with an evaporative light-scattering detector (ELSD) (Polymer Labs ELS-1000 
detector). 
 
Matrix-assisted laser desorption/ionization–time-of-flight (MALDI-TOF) mass 
spectra were recorded on a Voyager-DE
TM
 STR MALDI-TOF mass spectrometer 
(Applied Biosystems), with a matrix solution of sinapinic acid (10 mg/ml) in 49.9% 





















Scheme 2.5: Synthesis of CA-NLS 1. Reagents and Conditions: a) Rink amide linker 
(3 eq.), oxyma (3 eq.), diisopropylcarbodiimide (DIC) (3 eq.), 0.1 M in 
dimethylformamide (DMF), 3 h; b) 20% piperidine in DMF (2 x 5 min); c) AA (3 
eq.), oxyma (3 eq.), DIC (3 eq.) 0.1 M in DMF, 1 h; d) N-Fmoc-6-aminohexanoic 
acid (3 eq.), oxyma (3 eq.), DIC (3 eq.), 0.1 M in DMF, 3 h; e) 5(6)-carboxy 
fluoroscein (3 eq.), oxyma (3 eq.), DIC (3 eq.), 0.1 M in DMF, 3 h f) 90% TFA, 5% 






General conditions: All coupling reactions were carried out at rt unless otherwise 
stated. Solid-phase synthesis was performed manually using an Isolute filtration 
reservoir as the reaction vessel, fitted with polyethylene frits (Argonaut Technologies 
Inc). AAs were Fmoc protected, at the N terminus, with suitable acid labile 
protecting groups on the side chains. Each coupling step of the synthesis was 
assessed for completion using either the Kaiser test for primary amines, or the 




Kaiser Test: Solution 1: 80 g phenol in 20 ml ethanol (EtOH); Solution 2: 2 ml 
0.001 M aqueous KCN in 98 ml pyridine (Solution 1 and 2 combined make Solution 
A); Solution 3: 5 g Ninhydrin in 100 ml EtOH. (Solution B). 
 
Three drops Solution A and one drop Solution B were added to a few resin beads. 
The mixture was heated at 100 
o
C for 3 mins and the colour of the solution and beads 
was observed.  
 
 Positive result:  Resin/solution light to dark blue, i.e. primary amine 
present. 
 Negative result: Resin/solution colourless/light yellow, i.e. no primary 
amine present. 
 
Chloranil Test: Stock solutions should be kept in the refrigerator for no longer than 
one month. Solution A: 2% acetaldehyde in DMF; Solution B: 2% chloranil in DMF. 
Two drops of Solution A and two drops of Solution B were added to a few resin 
beads. The mixture was heated at 100 
o 
C for 3 mins and the colour of the solution 
and beads was observed. 
 
 Positive result: Resin/solution dark blue to green, i.e. primary or 
secondary amine present. 
 Negative result: Resin/solution colourless/light yellow, i.e. no primary 




Coupling the linker to the resin: Aminomethyl polystyrene resin (loading 1.23 
mmol/g, 0.20 g, 0.246 mmol) in a 6 ml reaction vessel was swollen for 5 mins in 
DCM (3 ml) and then washed with DCM (3 x 3 ml). To a solution of rink amide 
linker (399 mg, 0.74 mmol) in DMF (2.46 ml), oxyma (105 mg, 0.74 mmol) was 
added and the solution shaken for 10 mins. DIC (116 µl, 0.74 mmol) was added and 
the solution shaken for 2 mins. The mixture was added to the resin and shaken for 
3 h. The resin was filtered and washed with DMF (3 x 4 ml), DCM (3 x 4 ml) and 
methanol (MeOH) (3 x 4 ml). Kaiser test negative. The resin was washed with Et2O 
(3 x 4 ml) and dried under vacuum for storage. 
 
Coupling of AAs: The resin in a 6 ml reaction vessel was swollen for 5 mins in 
DCM (2.5 ml) and filtered. A solution of 20% piperidine in DMF (2.5 ml) was 
added, the vessel was shaken for 5 mins and the resin was filtered and washed with 
DMF (3 x 3 ml) and DCM (3 x 3 ml). Piperidine deprotection and washing cycle was 
repeated and the resin was dried under vacuum. Kaiser test positive. To a solution of 
the appropriate AA (0.74 mmol) in DMF (2.46 ml) was added oxyma (105 mg, 0.74 
mmol) and the solution shaken for 10 mins. DIC (116 µl, 0.74 mmol) was added and 
the solution shaken for 2 mins. The mixture was added to the resin and shaken for 1 
h. The resin was filtered and washed with DMF (3 x 3 ml), DCM (3 x 3 ml) and 
MeOH (3 x 3 ml). Kaiser test negative. Otherwise treatment of activated AA was 
repeated.  
 
Attachment of spacer to 8-mer resin: Resin (~0.246 mmol) in a 3 ml reaction 
vessel was swollen for 5 mins in DCM (2.5 ml) and filtered. A solution of 20% 
piperidine in DMF (2.5 ml) was added. The vessel was shaken for 5 mins and the 
resin was filtered and washed with DMF (3 x 3 ml) and DCM (3 x 3 ml). Piperidine 
deprotection and washing cycle was repeated and the resin was dried under vacuum. 
To a solution of N-(Fmoc)-6-aminohexanoic acid (262 mg, 0.74 mmol) in DMF 
(2.46 ml) was added oxyma (105 mg, 0.74 mmol) and the solution shaken for 10 
mins. DIC (116 µl, 0.74 mmol) was added and the solution shaken for 2 mins. The 
mixture was added to the resin and then shaken for 3 h. The resin was filtered and 
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washed with DMF (3 x 4 ml), DCM (3 x 4 ml) and MeOH (3 x 4 ml). Chloranil test 
negative. 
 
Attachment of Fluorescein to Spacer-8-mer resin: Resin (~0.246 mmol) in a 6 ml 
reaction vessel was swollen for 5 mins in DCM (2.5 ml) and filtered. A solution of 
20% piperidine in DMF (2.5 ml) was added. The vessel was shaken for 5 mins and 
the resin was filtered and washed with DMF (3 x 3 ml) and DCM (3 x 3 ml). 
Piperidine deprotection and washing cycle was repeated and the resin was dried 
under vacuum. To a solution of 5(6)-carboxyfluorescein (272 mg, 0.74 mmol) in 
DMF (2.46 ml) was added oxyma (105 mg, 0.74 mmol) and the solution shaken for 
10 mins. DIC (116 μL, 0.74 mmol) was added and the solution shaken for 2 mins. 
The mixture was added to the resin and shaken for 3 h. The resin was filtered and 
washed with DMF (3 x 4 ml), DCM (3 x 4 ml) and MeOH (3 x 4 ml). Process was 
repeated until negative Kaiser test obtained. The resin was swollen in DCM (3 ml) 
and washed with 20% piperidine in DMF (2 x 2.5 ml), DMF (6 x 2.5 ml), DCM (6 x 
2.5 ml) and MeOH (6 x 2.5 ml). The resin was washed with Et2O (3 x 2.5 ml), dried 
under vacuum and stored in the dark. 
 
Cleavage from resin: Resin (~0.246 mmol) in a 6 ml reaction vessel was swollen 
for 5 mins in DCM (2 ml) and filtered. A solution of TFA:TIS:DCM (90:5:5, 3 ml) 
was added, and the vessel was shaken for 3 h. The resin was removed by filtration, 
and ice-cold Et2O (30 ml) was added to the filtrate. The resultant solid was pelleted 
by centrifugation, and the solvent removed by decantation. Solid was dried under 
vacuum. 
 
Purification: CA-NLS 1 was purified using an Aglinet 1100 series HPLC: 
 
 Column: Phenomenex prodigy 5u C18, 250 × 10 mm, 5 μm. 
 Solvent: A-MeCN + 0.1% formic acid, B-H2O + 0.1% formic acid. 
 Method: 5%-95% A in B over 18 min, 2 min isocratic elution, 2 min to 5% A, 




CA-NLS 1 Characterisation Data: Yellow solid; HRMS (MALDI-TOF) 
C70H105N17O15S calc 1455.7783, found 1455.9723; ELSD retention time - 2.62 min 
(98% pure). 
 




Scheme 2.6: Synthesis of CA-NLS 2. Reagents and conditions: a) Rink amide linker 
(3 eq.), oxyma (3 eq.), DIC (3 eq.), 0.1 M in DMF, 3 h; b) 20% piperidine in DMF (2 
x 2 min); c) AA (0.2 M), HBTU (0.5 M), N,N-diisopropylethylamine (DIPEA) (2 M 




Solid-phase synthesis was performed using a CEM microwave peptide synthesiser. 
AAs were Fmoc protected at the N terminus, with suitable acid labile protecting 
groups on the side chains. All AA coupling reactions were carried out at 60 ºC unless 
otherwise stated. 
 
CA-NLS 2 was synthesized by solid phase methods, using standard Fmoc chemistry 
and a CEM Liberty microwave peptide synthesiser. Rink amide linker (399 mg, 0.74 
mmol) was coupled to aminomethyl PS resin (loading 1.23 mmol/g, 0.20 g, 0.246 
mmol), as described on page 28. After removal of the Fmoc-group using 20% 
piperidine in DMF, chain elongation was performed with Fmoc-Gly-OH, Fmoc-Gly-
OH, Fmoc-Val- OH, Fmoc-Lys(Boc)-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Lys(Boc)-OH, 
Fmoc-Lys(Boc)-OH, Fmoc-Lys(Boc)-OH Fmoc-Pro-OH, Fmoc Gly-OH, Fmoc Gly-
OH and Fmoc-Cys(Trt)-OH (each 0.2 M,), using 20% piperidine/DMF for Fmoc 
deprotection, HBTU (0.5 M) for activation, DIPEA (2 M in NMP) as base and DMF 
as solvent. After assembly of the linear peptide chain, the resin was transferred in 
several ml of DMF into a 6 ml Isolute filtration reservoir. The peptide was cleft from 
the resin, using TFA:TIS:DCM (90:5:5 3 ml). The resin was removed by filtration 
and ice-cold Et2O (30 ml) was added to the filtrate. The resulting solid was pelleted 
by centrifugation and the solvent removed by decantation. Solid was dried under 
vacuum. No purification was necessary. 
 
CA-NLS 2 Characterisation Data: White solid; HRMS (MALDI) C51H96N20O12S 












2.2 SERS Experiments 
 
2.2.1 General SERS Microscopy Information 
 
All SERS spectra were recorded with a Renishaw inVia Raman Microscope and 
Spectrometer. A 785 nm diode laser with ~6 mW power at the sample was used, 
along with a 50 × Olympus Long Working Distance objective (NA = 0.45), to focus 
laser light onto the gold nanoshells (NS). All SERS spectra were processed using 
WIRE
TM
 2.0 software. Aqueous suspensions of NS (3×10
9
 NS/ml, 5 pM) were 
purchased from Nanospectra Biosciences. NS were resonant at 780 nm and had a 125 
nm silica core and a 25 nm gold shell thickness. Aqueous suspensions of gold 
nanorods (NR) (6.1×10
11
 NR/ml, 1 nM) were purchased from Nanopartz. NR were 
resonant at 770 nm and had a 10 nm axial diameter and a 38 nm length.  
 
2.2.2 NS and NR Functionalisation  
 
NS were functionalised via overnight incubation of 1 mM solutions of HQ, NQ and 
AQ at rt. Solutions of HQ and FCBX were aqueous, whereas NQ and AQ were 
water:EtOH mixtures (9:1) and contained 5 mM tris(2-carboxyethyl)phosphine 
(TCEP). All NS were washed twice with distilled water after functionalisation. NR 
were functionalised with CA-NLS 1 and CA-NLS 2 via 72 h incubation in 0.1 mM 
aqueous peptide solutions. All NR were washed twice with distilled water after 
functionalisation. UV-Vis analysis was used to confirm attachment of analytes.   
 
2.2.3 SERS Characterisation of NLS Peptides 
 
SERS spectra were recorded for NLS peptides from the surface of NS, immobilised 
on aminosiloxane functionalised glass microscope slides. 5 μl of NS solution (100 
fM) were deposited on the slides. Water was left to evaporate, before 7.5 μl of 
coating solution (1 mM) were deposited over the NS. After overnight incubation at 
rt, slides were washed with distilled water to remove any loosely adsorbed 
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molecules. SERS spectra were acquired over 10 s and between a Stokes Raman shift 
range of 600-1800 cm
-1
. Vibrational assignments were made according to the 
literature.  
 
2.2.4 Spectroelectrochemistry  
 
3-Mercatopropionic acid (2 μl of a 5 mM ethanolic solution) was deposited onto the 
surface of gold microfabricated electrodes, which were incubated overnight at rt. The 
electrodes were carefully rinsed with water and allowed to dry at rt. Aqueous 1-
ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) solution (2 μl of a 24 mM 
solution) was deposited on the surface of the electrodes, which were incubated for 30 
min at rt. The electrodes were rinsed carefully with water and allowed to dry at rt. 
Poly-L-lysine solution (2 μl of a 0.1% (w/v) solution) was deposited onto the surface 
of the electrodes, which were incubated for a further 6 h at rt. After this time, 2 μl of 
NS (10 fM solution) were deposited onto the electrodes, which were subjected to a 
wash-dry step. Self assembled monolayers (SAMs) of the SERS reporters were 
formed on the NS by pipetting 2 μl of aqueous solutions of HQ, FCBX, or NQ (1 
mM) onto the NS. As stated previously, solutions of NQ were incubated with 5mM 
TCEP. Electrodes were carefully rinsed with water, in order to remove any loosely 
adsorbed molecules and left to dry at rt.  
 
Once functionalised with HQ, FCBX, or NQ, the gold microfabricated electrodes, 
along with a coiled platinum wire (0.1 mm diameter), serving as the auxiliary 
electrode, and coiled silver wire (0.5 mm diameter), serving as the reference 
electrode, were connected to Type III Autolab potentiostat, using GPES v4.9 
software to control the potential. The electrodes were inserted into a 20 ml glass Petri 
dish which was charged with phosphate buffer (0.1 M, pH 7.4, 0.1 M KCl). SERS 
spectra were then recorded, from the surface of the electrodes, at varying potentials. 
SERS spectra were acquired over 10 s and between a Stokes Raman shift range of 
200-1800 cm
-1
. Vibrational assignments were made according to the literature and 




For the AQ probe molecule, 200 μl of a 10 fM solution of AQ-NS were pipetted into 
a well of a 96-well plate. Solution RP was varied according to the Nernst equation, 
using the NADP
+
/NADPH redox couple. SERS spectra were recorded from the well 
at varying potentials. SERS spectra were acquired over 10 s and between a Stokes 




2.2.5 Redox Couple Solution Studies 
 
For redox couple solution studies, 5 μl of NS solution (100 fM) were deposited onto 
aminosiloxane functionalised slides. Water was left to evaporate before 7.5 μl of NQ 
solution (1 mM, 9:1 H20:EtOH, 5 mM TCEP) were deposited over the NS. RP was 
changed, using solutions in which ratios of reduced:oxidised species were altered 
with various redox couples according to the Nernst equation. Solution measurements 
were carried out in phosphate buffer (0.1 M, pH 7.4, 0.1 M KCl). For solution studies 
with NQ-NS, SERS spectra were acquired over 30 s and between a Stokes Raman 




2.2.6 Intracellular SERS Experiments  
 
Cells were seeded at a density of 2×10
5
 on 25 × 25 × 1 mm quartz coverslips (UQG 
Optics Ltd, UK) in 1 ml of media and incubated for 24 h. Functionalised NS 
(1,500 NS/cell, 249 fM) were then taken up by the cells through endocytosis in 2 ml 
of CS-free media overnight. In order to induce oxidative stress in cells, 2,2′ azobis-2-
amidinopropane (AAPH) was introduced into the media at a concentration of 
30 mM. In order to induce reductive changes in cells, dithiothreitol (DTT) was 
introduced into the media at a concentration of 1 mM. In order to induce apoptosis in 
cells, staurosporine was introduced into the media at a concentration of 1 μM (3 and 
6 h incubations). MicroRNA (miRNA) mimics or inhibitors were reverse-transfected 
into cells at a final concentration of 25 nM in 0.4% DharmaFECT 1 (Thermo Fisher 
Scientific). miRNA sequences were obtained from miRBase and purchased from 
Thermo Fischer Scientific. For intracellular studies with HQ-NS, SERS spectra were 





intracellular studies with NQ-NS, SERS spectra were acquired over 30 s and between 
a Stokes Raman shift range of 1340-1840 cm
-1
. All spectra were processed using 
WIRE
TM
 2.0 software. 
 
2.3 Cellular Work 
 
2.3.1   General Cell Culture Information 
 
All cellular work was carried out using NIH/3T3 mouse fibroblast cells. Cells were 
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM), supplemented with 
penicillin/streptomycin (10,000 units/ml), L-glutamine (200 mM) and 10% heat-
inactivated calf serum (CS) (all Gibco). Cells were incubated at 37 ºC and 5% CO2 in 
a humidified incubator.  
 
When handling cells for passage, old media was removed and cells were washed 
with phosphate buffered saline (PBS). Cells were harvested via trypsination (1 ml) 
(trypsin/ethylenediaminetetraacetic acid (EDTA), Gibco) at 37 °C and 5% CO2 for 3 
mins. The detached cells were re-suspended in fresh growth media and pelleted by 
centrifugation at 1,100 rpm for 5 mins. Appropriate aliquots were re-seeded for 
continued growth. 
 
When freezing cells for long term storage, cells were re-suspended in freezing media 
(90% culture media, 10% dimethyl sulfoxide (DMSO)). 1 ml aliquots (2×10
6
 
cells/ml) of re-suspended cells were pipetted into labelled 1.8 ml cryovials, 
transferred to a Nalgene Cryo 1 °C freezing container and stored overnight at -80 °C. 
The following day, cryovials were transferred into liquid N2.  
 
When thawing cells from liquid nitrogen storage, cryovials were removed from the 
liquid N2 and the cells thawed slowly in a warm water bath (37 °C). The outside of 
the cryovial was disinfected with 70% EtOH, and its contents transferred to a clean 
15 ml falcon tube, along with 10 ml of fresh media. The cells were centrifuged at 
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1,000 rpm for 5 mins and the supernatant discarded. The pellet was then re-
suspended in 5 ml of fresh media and transferred to a new 25 cm
2




Cell densities were determined by haemocytometry. An aliquot (10 μl) of cells 
detached from a culture flask and collected media (total volume: 5 ml) was mixed 
with 0.2% trypan blue (40 μL, Sigma-Aldrich) and pipetted into a Bright Line™ 
haemocytometer (an etched glass device with an H-shaped moat forming two cell-
counting areas, each with 4 quadrants and with surface features enhanced by 
Neubauer rulings).  
 
Cell concentrations were determined by Equation 2.1. 
 
C = (N/Q) × 5 × 10
4 
 
Equation 2.1: Cell concentration formula. Where C = Concentration (cells/ml), N = 
Number of cells and Q = Number of quadrants counted. 
 
2.3.3 DCFH-DA Assay 
 
A 96-well plate divided into four sections (untreated cells, NQ/HQ-NS) (1,500 
NS/cell, 149 fM), tBOOH +ve control (0.5 mM) and Zn +ve control (0.5 mM)) was 
seeded at a density of 12,000 cells per well in 200 μl of media. Cells were grown to 
~60% confluence overnight and the media was changed to 2% CS. Cells were left to 
grow on overnight, until confluence was reached. Old media was removed and 
replaced with phenol-red, CS-free media. At this time, cells were treated with 
NQ/HQ-NS and positive controls overnight. Cells were washed twice with PBS. Old 
media was removed and replaced with phenol-red, CS-free media (100 μl) along with 
DCFH-DA (100 μl of a 40 μM solution). The plate was incubated for 30 mins. 
Following incubation with DCFH-DA, old media was replaced with fresh phenol-
red, CS-free media. Fluorescence measurements were taken over a 24 h period at 
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intervals of 0, 1, 2, 3, 4, 5, 6 and 24 h, using a BioTek Synergy HT plate reader 
(excitation 485/20, emission 530/25 nm). 
 
2.3.4 Total GSH and GSSG Assay 
 
Cells were seeded at a density of 1.50×10
5
 cells/well in a 6-well plate (2 ml/well) and 
allowed to reach confluence (approx 6×10
5
 cells/well) over 48 h. The 6-well plate 
was divided into two sections (untreated and NQ/HQ-NS (1,500 NS/cell, 187 fM) 
treated cells). Cells were incubated overnight in CS-free media before being washed 
with PBS and harvested by trypsinisation. Harvested cells were subjected to 
deproteinisation with 0.1% Triton / 0.6% sulfosalicyclic acid in 0.1 M phosphate 
buffer with 5 mM EDTA (pH 7.5) (KPE) and homogenised by sonication. Cell debris 
was collected by centrifugation for 5 mins at 5,000 rpm 4 °C. Samples were stored 
on ice, prior to analysis of GSH content. GSH standards in KPE were prepared at 
concentrations of 8, 4, 2, 1, 0.5, 0.25 and 0.125 µg/ml by 2-fold serial dilutions of a 
16 µg/ml stock solution. Solutions of 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) 
and β-NADPH were also prepared in KPE at a concentration of 0.67 mg/ml, along 
with a GR solution, which was prepared at a concentration of 14 µl/ml in KPE. 
Standards and samples were added to the wells of a 96-well plate. Equal volumes of 
DTNB and GR solutions were mixed together and 120 µl of this mixture were added 
to each well. After incubating at rt for 30 s to allow for conversion of GSSG to GSH, 
60 µl of β-NADPH solution were added to each well. Absorbance values were then 
read at 412 nm using a BioTek Synergy HT plate reader. From the absorbance 
values, the rate of 2-nitro-5-thiobenzoic acid formation was calculated and, using 
linear regression, total GSH concentrations were calculated in triplicate. GSH 
concentrations were expressed in µM/mg of protein (as determined by the 
bicinchoninic acid assay (BCA)). GSH standard and GR were purchased from 
Cayman Chemical Company.  
 
Exclusive quantification of GSSG was achieved by derivatising GSH with 2-
vinylpyridine. After deproteinising cells, 5 μl of 2-vinylpyridine were added per ml 
of extraction buffer. The remainder of the assay was carried out as normal.   
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2.3.5 BCA Protein Assay 
 
Pierce BCA protein assay was carried out according to the manufacturer’s 
instructions.
77
 Briefly, 10 μl of cell lysate were added to the wells of a 96-well plate 
containing 100 μl of working reagent. The plate was incubated for 30 mins at 37 °C, 
allowed to cool to rt. Absorbances were then measured at 562 nm, using a BMG 
Labtech Polarstar microplate reader. Protein concentrations were determined from a 
standard curve, using bovine serum albumin (BSA) standards. The working range of 
BSA standards used was 25-1500 μg/ml. Working reagent and BSA standard were 
purchased from Thermo Fischer Scientific. 
 
2.3.6 APOPercentage Apoptosis Assay 
 
APOPercentage apoptosis assay was carried out according to the manufacturer’s 
instructions.
78
 Briefly, selected wells of a 96-well plate were seeded with cells at a 
density of 12,000/well (200 μl/well). Cells were allowed to settle and were incubated 
for 3 h. Old media was removed. Cells were washed three times with PBS and then 
incubated overnight in CS-free media with NQ/HQ-NS (1,500 NS/cell, 149 fM) or 
for 3 h with staurosporine (1 μM). Cells were carefully washed three times with CS-
free media before wells were charged with 100 μl of fresh CS-free media and 5 μl of 
APOPercentage Dye. After 30 mins incubation, cells were washed three times in 
PBS. Fluorescence measurements were recorded, using a BMG LabTech Fluostar 
Galaxy microplate reader (excitation 485/20 nm, emission 530/25 nm). 
 
2.3.7 Apo-ONE Apoptosis Assay 
 
Apo-ONE apoptosis assay was carried out according to the manufacturer’s 
instructions.
79
 Briefly, selected wells of a 96-well plate were seeded with cells at a 
density of 12,000/well (200 μl/well). Cells were allowed to settle and were incubated 
for 3 h. Old media was removed. Cells were washed three times with PBS and then 
incubated for 5 h with concentrations of H2O2 ranging from 0-10 mM. Cells were 
carefully washed three times with CS-free media before wells were charged with 100 
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μl of fresh CS-free media and 100 μl of Apo-ONE Caspase-3/7 Reagent. After 3 h 
incubation, cells were washed three times in PBS. Fluorescence measurements were 
recorded, using a BMG LabTech Fluostar Galaxy microplate reader (excitation 
485/20 nm, emission 530/25 nm). 
  
2.3.8 MTT Assay 
 
Cells were seeded at a density of 6,000/well (columns 2, 4 and 6 and rows A-H) in a 
96-well plate (100 μL per well). Column 8 was used as a blank (no cells). Cells were 
incubated for 24 h prior to NQ/HQ-NS (1,500 NS/cell, 75 fM) / NR-NLS (6,000 
NR/cell, 300 fM) treatment in CS-free media for 24 h. After the desired incubation 
time, old media was removed, cells were washed twice with PBS and the wells 
charged with fresh phenol-red free media (90 μL). 10 μL of MTT at concentration of 
5 mg/ml in PBS was added to each well. Cells were incubated for 3 h, prior to 
dissolution of the formed formazan, using 100 μL of the MTT solubilising solution 
(10% TRITON X-100, 0.1 N HCl in IPA) and gently shaking until total dissolution 
of the crystals. Absorbance values were read, on a BIO-RAD Benchmark microplate 
reader, at 570 nm and cellular viability was calculated according to equation 2.2. 
 
% Cell Viability = (A570 Exp / A570 Control) × 100 
 
Equation 2.2: Cell viability formula. Where A570 Exp = Absorbance form 
experimental sample and A570 Control =  Absorbance from control sample. 
 
2.3.9 Fluorescence Imaging of CA NLS 1-NR in Cell Nuclei 
 
Cells were seeded at a density of 12,000 in a 96-well plate (200 μl/well) and grown 
to confluence (24 h). After washing the cells three times with PBS, 200 µl of fresh 
media containing CA NLS 1-NR (6,000 NR/cell, 598 fM) were added. Cells were 
incubated overnight before being washed three times with PBS. 198 µl of PBS and 
2 µl of Höescht dye (1 mM aqueous solution) were added to each well. Cells were 
incubated with Höescht dye for 10 mins before being washed three times with PBS. 
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Fluorescence imaging was carried out using a Lecia fluorescence microscope with 
appropriate filters.   
 
2.3.10 Transmission Electron Microscopy (TEM) of 
Nanoparticles in Cells 
 
Cells were grown to confluence (approximately 1.5×10
5 
cells/slip) on Agar Scientific 
Thermanox cover slips (10.5 × 22 mm) and were incubated overnight with NQ/HQ-
NS (1,500 NS/cell, 373 fM) or CA-NLS 2-NR (6,000 NS/cell, 1.50 pM) in 1 ml of 
CS-free media. The cells were washed three times with PBS and were fixed for 2 h in 
3% (v/v) glutaraldehyde in 0.1 M sodium cacodylate buffer. The cells were then 
washed three times with 0.1 M sodium cacodylate buffer, followed by post fixation 
overnight with 1% (w/v) osmium tetroxide in 0.1 M sodium cacodylate buffer. The 
cells were washed with 0.1 M sodium cacodylate buffer, then dehydrated with 
acetone (50%-100%, in steps of 50%, 70%, 90% and 100%) and then infiltrated and 
embedded in epoxy resin. Ultra-thin sections of the sample were taken using a 
diamond knife. The sections were positioned on grids and stained with 2% aqueous 
uranyl acetate. The grids were then examined and photographed at an accelerating 
voltage of 80 keV in a CM120 Biotwin (Philips) transmission electron microscope 













2.4  Other Experimental Techniques 
 
2.4.1  Aminosiloxane Functionalisation of Glass Microscope Slides 
 
Slides were immersed in a 2.5 M NaOH solution (60:40 / EtOH:H2O) for 2 h, before 
being rinsed thoroughly with water and dried by centrifugation. Cleaned slides were 
immersed in an ethanolic solution of 3-aminopropyl trimethyl siloxane (2% v/v) for 
1 h, before being rinsed thoroughly with EtOH and dried by centrifugation.  
 
2.4.2 DFT Vibrational Assignments 
 
The optimised geometry and Raman-active vibrational modes of oxidised and 
reduced probe molecules were calculated using DFT at the B3LYP/LANL2DZ level 
of theory. All calculations were carried out using Becke’s three-parameter exchange 
functional, coupled with the Lee-Yang-Parr correlation functional (B3LYP),
80,81
 in 
combination with the LANL2DZ basis set of Hay and Wadt.
82,83,84
 This comprises an 
effective core potential (ECP) plus double zeta basis for heavy atoms, with the all 
electron valence double zeta basis set developed by Dunning (D95V) for lighter 
atoms.
85 All calculations were carried out using the Gaussian 03 software package. 
For each molecule, unconstrained geometry optimisations were carried out, followed 
by frequency calculations, in order to determine the character and frequency of the 
Raman-active vibrational modes. The absence of imaginary frequencies was used to 
confirm that each calculated structure was a minimum on the molecular potential 
energy surface. 
 
To investigate any effects resulting from reporter molecule proximity to the gold 
surface, calculations were also run on equivalent molecules with the terminal gold 
atoms replaced with hydrogen atoms. No significant changes in the predicted 
vibrational spectra were observed. 
  
Vibrational mode assignments were based on visual inspection of the calculated 
modes, which were animated using the Gabedit v2.0.7. software package. 
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Figure 2.1 below shows a flow diagram which outlines the process involved in the 
DFT calculations.  
 
Figure 2.1: Flow chart showing the process of assigning Raman vibrations with DFT 
calculations. Molecules were first drawn with Argus Lab, they then had their 
geometry optimised and vibrational modes predicated with Gaussian 03 before the 
vibrations were animated with Gabedit and assigned in conjunction with the 




(1) Molecules drawn 
with Argus Lab 4.0 
software. 
 
(2) Geometry of 
molecules optimised 
with Gaussian 03 
software. 
(3) DFT calculations 
performed with 
Gaussian 03 to obtain 
predicted Raman-active 
vibrations.   
(4) Predicted vibrations 
animated with Gabedit 
v.2.0.7 software.  
(5) In conjunction with 
literature, experimental 
vibrations assigned from 
DFT predicted spectra.   
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2.4.3  Cyclic Voltammetry 
 
Cyclic voltammograms (CVs) were obtained with a Type III Autolab potentiostat 
using GPES v4.9 software for results analysis. A conventional three-electrode cell 
was used, with a coiled platinum wire (0.1 mm diameter) serving as the auxiliary 
electrode and a coiled silver wire (0.5 mm diameter) serving as the pseudo-reference 
electrode. A gold Metrohm electrode (7.07 mm
2
) served as the working electrode. 
The CVs of the quinone and ferrocene SAMs were recorded in phosphate buffer (0.1 
M, pH 7.4, 0.1 M KCl). All solutions were degassed by nitrogen bubbling for 30 
mins. 
 
2.4.4  UV-Vis Spectroscopy 
 
Solutions containing NS, NR, probe molecule-NS and peptide molecule-NR were 
measured in an ATI UNICAM UV-2 UV-vis for their UV-vis spectra. The solutions 
were loaded in a 1 ml cuvette and the spectra recorded from 550 to 900 nm. 
 
2.4.5 Ratio Error Calculation and Nernst Fitting 
 
The spectral intensity ratios (a) used to determine redox potential values can be 
represented as a = b/c (where b and c are the intensities of the peaks used to calculate 
a). The errors (Δa) associated with spectral ratios were calculated using equation 2.3 
by combining/propagating the individual errors (standard deviations) associated with 





Equation 2.3: Formula used to calculate errors in spectral ratios. Where Δa = error 
in ratio, a = mean ratio, Δb = standard deviation of intensity in peak b, b = mean 
intensity of peak b, Δc = standard deviation of intensity in peak c and c = mean 










The data in figures 3.10, 3.12, 3.13 and 3.15 were fitted to the Nernst equation using 







Equation 2.4: Nernst fitting equation. Where [Red] = fraction of reduced species, 














Development and Characterisation of 




‘You must learn to walk before you can run.’ 
-Proverb 
 
Before any relevant biological redox measurements were made, nanosensors that 
were fit for purpose had to be developed and characterised. The hypothesis that a 
molecule’s SERS fingerprint could change quantitatively with potential also had to 
be investigated. In this chapter, results are presented on the design and fabrication of 
SERS-active redox nanosensors and their electrochemical properties. A series of 
spectroelectrochemical proof of concept experiments is also detailed. 
 
As outlined in chapter 1, the prerequisite for an ideal redox monitoring system is the 
ability to monitor potential: 
 
 In live cells, quantitatively and reversibly, with optimal spatiotemporal 
resolution. 
 At a sub-cellular resolution. 
 Over a wide potential range, covering hypoxia and oxidative stress. 
 
With the above in mind, nanosensors based on SERS were conceived, constructed 
and assessed through novel spectroelectrochemical experiments. The SERS 




(1) NS – See section 1.4.3 (pages 26-27) for a full description of NS. 
 
(2) Redox-active molecules (RAMs) – Most of the RAMs contained quinone 




 redox reactions in buffered aqueous 
solutions, resulting in a change in their molecular structure.
14,86
 A ferrocene-based 
RAM, which undergoes a reversible 1e
-
 redox process in both aqueous and organic 
media, was also synthesised.
14,86
 All RAMs possessed thiol or disulfide 











redox reactions in buffered aqueous solutions and (B) ferrocene – which undergoes 
reversible 1e
-
 reactions in buffered aqueous media . 
 
Using standard organic chemistry, the core moieties shown in figure 3.1 can be 
modified to increase or decrease their reduction potentials as required. This would 
enable a library of compounds to be synthesised which could cover the theoretical 
electrochemical window of the cell from -315 mV to 820 mV as defined by NADPH 








3.2 RAM Synthesis and Electrochemical Characterisation 
 
3.2.1 Synthesis and Electrochemistry of AQ 
 
Anthraquinone-2-carboxylic acid was first reacted with thionyl chloride (a powerful 
inorganic chlorination reagent). This converted its carboxyl group into a more 
reactive acyl chloride group, in order to ensure more efficient amide bond formation 
with cystamine in the second step. Nucleophilic attack of the acyl chloride carbonyl 
carbon of anthraquinone-2-carbonyl chloride (2 eq.) by cystamine’s terminal amine 




Scheme 3.1: Mechanism of AQ synthesis. Anthraquinone-2-carboxylic acid is first 
converted to anthraquinone-2-carbonyl chloride by thionyl chloride. Two equivalents 
of anthraquinone-2-carbonyl chloride are then reacted with cystamine via 
nucleophilic attack to yield AQ.    
 
Electrochemical reversibility was a prerequisite for the RAMs used in this work, to 
enable monitoring of both oxidative and reductive changes in potential. For 
surface-adsorbed species in ideal conditions, electrochemical reversibility is 
indicated by symmetric and coincidental reduction and oxidation peaks (due to 
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electrode reactions being controlled only by electron transfer kinetics and not limited 
by diffusion).
14 
Furthermore, oxidation:reduction peak height (current) and peak area 
















E/mV vs. NHE (pH 7.2)
 
Figure 3.2: CV of an AQ SAM on a gold electrode in buffered solution (pH 7.2). 
Scan rate = 0.1 V/s 
 
The CV of a SAM of AQ on a gold electrode revealed a reversible electrochemical 
process with a half-wave potential (E1/2) of -312 mV (figure 3.2).  
 
As expected, the CV of AQ’s SAM did not display ideal electrochemical reversibility 
for a surface-adsorbed species. There was a peak separation of 59 mV between the 
reduction and oxidation peaks. This is because the electrode reactions involve 
protonation/de-protonation steps where protons are transferred to and from the 
buffered electrolyte solution.
14,86
 These reductions and oxidations are, therefore, 
governed by both electron transfer kinetics and diffusion.
14
 Indeed, this is the case 
for all of the quinone based RAMs. However, analysis of the AQ SAM’s 
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oxidation:reduction peak height and peak area ratios both approximate to 1 and a plot 
of iOx vs. scan rate was linear (see appendix 1 for data). These traits indicated 
electrochemical reversibility.   
 
3.2.2 Synthesis and Electrochemistry of NQ 
 
NQ was formed in a substitution reaction. Cystamine’s nucleophilic terminal amine 
groups attacked the 2-position of 2,3-dichloro-1,4-naphthoquinone to give NQ as a 
deep red solid (scheme 3.2). 
 
 
Scheme 3.2: Mechanism of NQ synthesis. The terminal amine groups of cystamine 
attack the 2-position of 2,3-dichloro-1,4-naphthoquinone to yield NQ.  
 
The CV of a NQ SAM on a gold electrode revealed a reversible electrochemical 
process with an E1/2 of -283 mV (figure 3.3). Due to there being less electron density 
within NQ, it was expected that its E1/2 would be higher than AQ (i.e. NQ would be 













E/mV vs. NHE (pH 7.2)
 
Figure 3.3: CV of a NQ SAM on a gold electrode in buffered solution (pH 7.2). 
Scan rate = 0.1 V/s. 
 
As with the AQ SAM, ideal electrochemical reversibility was not observed. There 
was also separation between the reduction and oxidation peaks (60 mV in this case). 
However, this was again to be expected and further analysis revealed 
oxidation:reduction peak height and peak area ratios both approximate to 1 and a plot 
of iOx vs. scan rate was linear (see appendix 1 for data). 
 
3.2.3 Synthesis and electrochemistry of HQ 
 
The two-step synthesis of HQ firstly involved a Michael-type reaction of sodium 
thiosulfate with 1,4-benzoquinone. In the second step, the resulting 2-thiosulfate-1,4-










Scheme 3.3: Mechanism of HQ synthesis. 
 
The CV of a SAM of HQ on a gold electrode revealed a reversible electrochemical 
process with an E1/2 of 130 mV (figure 3.4). There is considerably less electron 













E/mV vs. NHE (pH 7.2)
 
Figure 3.4: CV of a HQ SAM on a gold electrode in buffered solution (pH 7.2). The 
scan rate is 0.1 V/s. 
 
Once again, there was a separation between the reduction and oxidation peaks (102 
mV in this case). However, inspection of the oxidation:reduction peak height and 
peak area ratios revealed that both were approximate to 1 and the plot of iOx vs. scan 





3.2.4 Synthesis of FCBX 
 
In a similar fashion to AQ, FCBX was formed via an amide bond linkage (in this 
instance, between fluorocarbonylferrocene and cystamine). Ferrocene carboxylic 
acid was first converted into fluorocarbonylferrocene using cyanuric fluoride as a 
mild fluorinating reagent. As is the case with the reaction of acyl chlorides and 
amines, conversion of carboxyl groups to more reactive acyl fluorides ensures more 
efficient amide formation in their reaction with amines.
88
 Fluorocarbonylferrocene 
was used instead of chlorocarbonylferrocene, due to the relatively low yields and 
instability of the latter.
75
 Through nucleophilic attack by cystamine’s terminal amines 
on the carbonyl carbon of fluorocarbonylferrocene, FCBX was formed as bright 
orange crystals (scheme 3.4). 
 
 
Scheme 3.4: Mechanism of FCBX synthesis. 
 
The CV of a SAM of FCBX on a gold electrode revealed a reversible 




Figure 3.5: CV of a FCBX SAM on a gold electrode in buffered solution (pH 7.2). 
The scan rate is 0.1 V/s. 
 
Electrochemical reversibility was indicated by the oxidation:reduction peak height 
and peak area ratios being approximate to 1 and the plot of iOx vs. scan rate for 
FCBX being linear (see appendix 1 for data). However, deviation from reversible 
electrochemical behaviour was observed through a peak separation of 62 mV. This 
was not entirely unexpected, as there is still a diffusion process involving the Cl
- 

















3.2.5 Theoretical Range of SERS-Active Redox Nanosensors  
 
By taking the E1/2 values for each probe molecule (as determined by CV) and varying 
the ratio of reduced:oxidised species it was possible to generate theoretical plots of 
the potential range in which they could monitor according to the Nernst equation 
(page 2). For each quinone probe molecule n was set to equal two and it was 




 redox reaction without 
intermediary formation of semi-quinone. For the FCBX probe molecule, n was set to 
equal one. Figure 3.6 below shows the theoretical potential ranges that it would be 

















Figure 3.6: Theoretical potential window of nanosensor library as determined by the 
Nernst equation. Potential range of: AQ (black line); NQ (blue line); HQ (green 
line); and FCBX (red line). 
 
 


















While NQ, which as an E1/2 similar to that of GSH, would be useful for monitoring 
subtle changes in IRP, the Nernstian plots reveal that AQ, with its lower, more 
negative E1/2, would be useful for monitoring hypoxic potentials. On the other hand 
HQ and FCBX have far greater E1/2 values than NQ and, therefore, would be 
potentially suited to monitoring events and processes associated with oxidative stress 
events. With sensitivities of the probe molecules decreasing as they are near to being 
fully oxidised or reduced, there is a need to ‘plug the gaps’ in figure 3.6 in order to 
be able to accurately monitor the full theoretical potential window of the cell.   
 
3.3 SERS Spectroelectrochemistry  
 
In order to quantify oxidation state dependent changes in the vibrational modes of the 
RAMs, SERS spectroelectrochemistry was employed. Two spectroelectrochemical 
methods were developed during this work: 
 
(1) Electrode Spectroelectrochemistry – In these experiments, nanosenors were 
immobilised on the surface of microfabricated gold electrodes. Using a potentiostat, 
the potential was varied and SERS spectra were recorded from the surface to 
determine if it would be possible to link potential changes quantifiably with changes 
in the SERS fingerprints of RAMs. 
 
To anchor nanosensors to the gold electrodes, a poly-L-lysine coating was deposited 
across their surface. In order to achieve this, a layer of mercaptopropionic acid was 
first chemisorbed onto the gold electrodes through Au-S bonds. The carboxyl groups 
of the acid were then activated with EDC, before forming amide bonds with poly-L-
lysine. Creating a poly-L-lysine coating had the effect of fashioning the electrode 
surface with free amine groups. This allowed NS to bind to the electrode surface 
through electrostatic interactions.
89
 After surface attachment of NS, a SAM of RAMs 
was then formed and SERS spectra were recorded at varying potentials.  
 






Figure 3.7: Assembly of nanosensors for spectroelectrochemistry. Gold electrodes 
were first functionalised with mercaptopropionic acid before being coupled to poly-
L-lysine with EDC. NS were then deposited on the surface of the electrodes and 
functionalised with RAMs. 
 
Au Electrode 











In order to ascertain whether nanosensors had been successfully immobilised, 3-D 
atomic force microscopy (AFM) images were recorded in tapping mode over the 
surface of the gold electrodes. AFM works by measuring the forces between the 
surface of a chosen sample and a probe tip attached to the end of a vertically 
oscillating cantilever.
90
 In tapping mode, the probe tip lightly contacts the analyte 
surface on the bottom of its swing ensuring minimal sample damage.
90
 As the probe 
tip moves over the sample, laser light is reflected from the top of the cantilever onto 
a photodiode.
90






Figure 3.8: 3-D AFM image of nanosensors on the surface of a microfabricated 
electrode. 
 
Figure 3.8 shows a 3-D topographic image of nanosensors (raised white columns) 
immobilised on the surface of a gold electrode (red background). The raised white 
areas are ~150 nm in height and clearly confirm the success of nanosensor (also ~150 
nm) immobilisation on gold electrodes.    
 
(2) Redox Couple Spectroelectrochemistry – In these experiments, the RP of 
aqueous solutions (containing nanosensors) was varied according to the Nernst 
equation - that is, by varying the ratio of [oxidised]:[reduced] species of soluble 
cellular redox couples. SERS spectra were then recorded from the nanosensors in 
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solution and any quantifiable changes in RAM fingerprint were correlated with 
potential. 
 
This method was developed as an alternative to electrode spectroelectrochemistry. 
Like electrode spectroelectrochemistry, spectroelectrochemistry with soluble cellular 
redox couples is also a useful technique for investigating whether or not a particular 
probe molecule’s SERS fingerprint is sensitive to oxidation state changes. In fact, 
solution spectroelectrochemistry is a more representative model of the cellular 
interior in which the nanosensors would be expected to operate.   
 
3.3.1 Electrode Spectroelectrochemistry of HQ-NS  
 
Figure 3.9 shows the structure of HQ along with its E1/2 value and redox reaction 
scheme. It also shows SERS spectra of HQ-NS, immobilised on gold microfabricated 
















Figure 3.9: Spectroelectrochemistry of HQ-NS. SERS spectra of HQ-NS 
immobilised on gold electrodes were recorded at potentials ranging from -12 to 370 
mV. 
 
Using DFT at the B3LYP/6-31g(d,p) level, in accordance with the literature,
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individual vibrational modes of oxidised and reduced HQ-NS were assigned (Tables 
3.1 and 3.2). Predicted spectra showed excellent correlation with the observed 
spectra. DFT calculations to predict spectra were undertaken in collaboration with P. 
Richardson (University of Edinburgh).  
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Wavenumber (cm-1) Assignment 
356 Carbon framework angle bending 
428 C-H angle bending 
477 C=C angle bending 
841 C-C stretching 
983 Out-of-plane C-H wagging w/ C-C stretching 
1263 Symmetric ring breathing 
1525 C=C stretching 
1602 Asymmetric ring breathing 
1633 C=C stretching w/ C=O stretching 
 
Table 3.1: Vibrational assignments of oxidised HQ. 
 
Wavenumber (cm-1) Assignment 
428 C-H angle bending 
477 C=C angle bending 
895 Out-of-plane C-H wagging w/ carbon 
framework angle bending 
1041 C-H angle bending w/ Ar ring stretching 
1117 C-H stretching w/ O-H stretching  
1263 Symmetric ring breathing 
1585 Asymmetric ring breathing 
 
Table 3.2: Vibrational assignments of reduced HQ. 
 
Several features showed a marked potential dependent, change in intensity and 
frequency. Among these, the peak at 358 cm
-1
 which corresponds to carbon 
framework angle bending; the peak at 1263 cm
-1
 which corresponds to symmetric 
ring breathing; and the peak at 1585 cm
-1
 which splits from a singlet to a triplet 
corresponds to the asymmetric ring breathing, C=C stretching and C=O stretching 
vibrational modes. When the normalised intensity of the peak at 358 cm
-1
 was plotted 
against potential, the midpoint potential (at which equal amounts of reduced and 
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oxidised species are present) correlated well with the half-wave potential, further 
confirming that the SERS measurement reported accurately on the oxidation state of 















Figure 3.10: RP range covered by HQ-NS. Error bars show the standard deviation of 
three measurements. Points indicate SERS spectroscopic measurements. Solid lines 
(fitted using Origin 8.0) represent plots of the Nernst equation on the basis of E1/2 
measured by CV. 
 
For a full description of the ratio error calculations along with the Nernst fitting 
procedure refer to chapter 2 pages 50-51.  
   
3.3.2 Electrode and Redox Couple Spectroelectrochemistry of NQ-
NS 
 
Figure 3.11 shows the structure of NQ along with its E1/2 value and redox reaction 
scheme. It also shows SERS spectra of NQ-NS at potentials ranging from -394 to 
-194 mV vs. NHE (pH 7.2), recorded using electrode spectroelectrochemistry. 
 





























































Figure 3.11: Spectroelectrochemistry of NQ-NS. SERS spectra of NQ-NS 
immobilised on gold electrodes were recorded at potentials ranging from -394 to -
194  mV. 
 
Similar to HQ-NS, experimental and predicted spectra for NQ-NS correlated well. 




Wavenumber (cm-1) Assignment 
280 Out-of-plane C-Cl wagging 
339 S-Au stretching 
417 Out-of-plane C=O wag w/ aliphatic C-C angle bending 
440 Carbon framework angle bending 
475 Carbon framework angle bending 
654 C-S stretch 
1018 Ar ring stretching 
1072 Aliphatic C-C stretching 
1110 Aliphatic C-H wagging w/ C-C ring stretching 
1225 Out-of-plane Ar C-H wagging w/ Aliphatic C-H 
wagging 1253 In-pla e Ar C-H wagging w/ aliphatic C-H wagging 
1577 Symmetric ring breathing 
1602 Ar ring stretching w/ N-H wagging 
1645 C=O stretching w/ Ar ring stretching 
 
Table 3.3: Vibrational assignments of oxidised NQ. 
 
Wavenumber (cm-1) Assignment 
280 In-plane C-Cl wagging 
380 Out-of-plane O-H wagging  
415 Carbon framework angle bending 
455 Carbon framework angle bending 
691 C-S stretch w/ carbon framework angle bending 
798 Aliphatic C-H wagging 
833 Ar C-H angle bending w/ O-H angle bending 
1030 Aliphatic C-H wagging w/ Ar ring stretching 
1071 Aliphatic C-C stretching 
1111 Aliphatic C-H wagging w/ Ar ring stretching 
1261 In-plane Ar C-H wagging 
1577 Symmetric ring breathing 
 
Table 3.4: Vibrational assignments of reduced NQ. 
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As expected, several distinct potential dependent spectral changes were noted at 
potentials more reducing than those of HQ-NS. Vibrational modes which changed as 
a result of oxidation state included the in-plane C-Cl wagging at 280 cm
-1
, the 
doublet at 798-833 cm
-1
, which corresponded to aliphatic C-H wagging and aromatic 
C-H angle bending and the peak at 1576 cm
-1
, which splits from a singlet to a triplet 
corresponding to symmetric ring breathing, aromatic ring stretching and C=O 
stretching. When the normalised intensity of the peak at 1645 cm
-1
 was plotted 
against potential, the mid-point potential correlated well with the half-wave potential 
(figure 3.12). Again, this confirmed that SERS spectra report on the oxidation state 
















Figure 3.12: RP range covered by NQ-NS. Error bars show the standard deviation of 
three measurements. Points indicate SERS spectroscopic measurements. Solid lines 
represent plots of the Nernst equation on the basis of E1/2 measured by CV. 
 
In addition to electrode spectroelectrochemistry, quantifiable potential changes were 
observed from NQ-NS SERS spectra recorded in phosphate buffer solutions 
containing varying ratios of several soluble redox couples. The three redox couples 





























































The Nernst equation for the GSH/GSSG and CyS/CySSyC redox couples can be 
represented as follows: 
 
E = -252 – 30 log ([GSH]
2
/[GSSG]) mV 
at pH 7.2 and 25 °C. 
 
Equation 3.1: Nernst equation for the RP of the GSSG/2GSH half-cell. 
  
E = -240 – 30 log ([CyS]
2
/[CySSyC]) mV 
at pH 7.2 and 25 °C.  
 




 redox couple, the Nernst equation can be represented as: 
 
E = -327 – 30 log ([NADPH] /[NADP
+
]) mV 
at pH 7.2 and 25 °C.  
 




In each case, these cellular redox couples performed electron transfer to or from NQ-
NS (figure 3.13). In the case of NADPH/NADP
+
, however, only the 10% fully-
oxidised NADP
+
 was a strong enough oxidising agent to oxidise NQ-NS. This 
suggests that NQ-NS measures a cellular redox state which takes into account more 








































































































































Figure 3.13: RPs, measured using NQ-NS, in the presence of varying ratios of 
cellular redox couples. (A) CyS/CySSyC; (B) GSH/GSSG; (C) NADPH/NADP
+
. In 
the case of NADPH/NADP
+
, only the 0% and 10% reduced samples are sufficiently 
oxidising to give a measurable sensor response. Error bars represent standard 
deviations of three measurements. 
 
3.3.3 Redox Couple Spectroelectrochemistry of AQ-NS 
 
AQ-NS has an E1/2 value similar to that of the important cellular redox couple 
NADPH/NADP
+
 (E1/2 = -327 mV). AQ-NS SERS spectra would, therefore, be 
expected to vary in a Nernstian fashion in phosphate buffer solutions containing 





Figure 3.14 shows the structure of AQ along with its E1/2 value and redox reaction 
scheme. It also shows SERS spectra of AQ-NS at potentials ranging from -417 to 
-271 mV vs. NHE (pH 7.2) recorded in phosphate buffer solutions containing 





Figure 3.14: Spectroelectrochemistry of AQ-NS. SERS spectra of AQ-NS 
immobilised on gold electrodes were recorded at potentials ranging from -417 to -
271 mV. 
0 500 1000 1500 2000 
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As expected, several distinct potential-dependent spectral changes were noted at 
potentials more reducing than those of NQ-NS. Vibrational modes, which notably 
changed as a result of oxidation state, included the out-of-plane aromatic C-H 
wagging at 876 cm
-1
, the aromatic C-C stetching at 1453 cm
-1
, the peak at 1606 cm
-1
, 
which splits from a singlet to a doublet corresponding to amide stretching w/ 
symmetric ring breathing, and quinone C=O stretching. When the normalised 
intensity of the peak at 876 cm
-1
 was plotted against potential, the midpoint potential 
















Figure 3.15: RP range covered by AQ-NS. Error bars show the standard deviation of 
three measurements. Points indicate SERS spectroscopic measurements. Solid lines 
represent plots of the Nernst equation on the basis of E1/2 measured by CV. 
 
Similar to NQ-NS and HQ-NS, experimental and predicted spectra for AQ-NS 
























































Wavenumber (cm-1) Assignment 
410 Out-of-plane amide N-H wagging w/ carbon 
framework angle bending 
861 Out-of-plane aromatic C-H wagging 
1030 Aromatic C-C stretching 
1077 Aliphatic C-C stretching 
1175 Aliphatic C-H stretching 
1595 Amide stretching w/ symmetric ring breathing 
1668 Quinone C=O stretching 
 
Table 3.5: Vibrational assignments of oxidised AQ. 
 
Wavenumber (cm-1) Assignment 
413 Out-of-plane N-H wagging w/ carbon framework 
angle bending 
878 Out-of-plane aromatic C-H wagging 
1046 Aromatic C-C stretching 
1079 Aliphatic C-C stretching 
1256 In-plane Ar C-H wagging w/ aliphatic C-H wagging 
1450 Aromatic C-C stretching 
1606 Amide stretching w/ symmetric ring breathing  
 











3.3.4 Spectroelectrochemistry of FCBX 
 
Figure 3.16 shows the structure of FCBX along with its E1/2 value and redox reaction 
scheme. It also shows SERS spectra of FCBX-NS at potentials of 244 and 619 mV 
vs. NHE (pH 7.2). 
 
 
Figure 3.16: Spectroelectrochemistry of FCBX-NS at a reducing potential of 244 
mV and an oxidising potential of 619 mV. 
 
Unlike HQ-NS or NQ-NS, no potential-dependent changes were observed in the 
SERS spectra of FCBX-NS. DFT calculations also showed no significant changes in 
the spectra of FCBX-NS with oxidation state. One possible explanation is that, 
whereas with the quinone RAMs there is a change in molecular structure (most 
notably the oxidation of hydroxyl or carbonyl groups and changes in the aromaticity 
of the rings),
14,86
 the redox reaction of FCBX is occurring at the iron centre and, 
whilst there is a change in the electronic structure, there appears to be no change in 
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E 1 /2 = 4 5 9 m V 
244 mV (Reducing E) 
619 mV (Oxidising E) 
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vibrational modes of the ring structures. For this reason, FCBX was discounted for 
further experiments. 
 
Wavenumber (cm-1) Assignment 
249 Framework deformations 
736 Aliphatic C-C stretching 
923 Cp C-C stretching 
1324 Cp-amide rocking 
1354 Cp C-C stretching 
1440 In-plane C-H wagging 
1560 In-plane N-H wagging 
1741 C=O stretching 
 


















A series of redox nanosensors with SERS fingerprints, that are sensitive to oxidation 
state changes, has been developed.  
 
It has been shown that, by using simple synthetic organic chemistry, the potential 
window in which a given probe operates can be selectively tuned. Further synthetic 
work would enable assembly of a larger array of SERS nanosensors, with which IRP 
could be studied across the theoretical electrochemical window of a cell.  
 
It has also been shown, through two spectroelectrochemical methods, that changes in 
SERS traces of RAMs are quantifiable and can be correlated with RP. These changes 
are both rapid and reversible, which offers an opportunity to monitor both reductive 
and oxidative changes in real time.  
 
To summarise, these nanosensors are exciting new analytical tools that offer users 
the opportunity to explore and monitor IRP and its modulation over a previously 
unattainable range. While FCBX does not show promise as a RAM, this is less of a 
concern for the study of eukaryotic systems, where the cell rarely explores the 













Before any attempts were made to measure and monitor IRPs, two important 
questions had to be answered: 
 
 Would it be possible for nanosensors to be controllably delivered into cells? 
 Would their introduction cause any cytotoxic side effects? 
 
Previously, through TEM studies, the Campbell group had demonstrated the uptake 
of bare NS by NIH/3T3 mouse fibroblast cells in CS-free DMEM growth media.
71
 
While the exact mechanism of NS uptake is still under investigation, it has been 
shown to be independent of energy, clathrin and cholesterol.
71
 With these CS-free 
culture conditions, NS were shown to reside predominantly in the cytoplasm after 
uptake and were not encapsulated in vesicles; nor were they coated in lipids.
71
 The 
NS used in this work were functionalised with monolayers of RAMs and, as such, 
possessed unique surface properties which may have affected their uptake by cells. It 
was, therefore, important to study their intracellular fate in a similar fashion to the 




Today, the presence of nanoparticles in everyday life is widespread. They are used in 








Figure 4.1: Examples of products and technologies containing nanoparticles. Top 
left – electronic circuit board where nanomaterials are now being used. Top right – 
sunscreen where ZnO nanoparticles have been used to block out harmful UV light. 




Despite their rapidly increasing popularity, some nanomaterials have been shown to 
cause harmful effects. Indeed, fullerenes, carbon nanotubes and metal oxide 
nanoparticles (such as TiO2) have been shown to cause an increase in ROS levels 
which can, of course, lead to oxidative stress, excessive inflammation, or 
biomolecule damage.
96,97,98
 Exposure to these materials has even been implicated in 




One of the accepted mechanisms of nanoparticle cytotoxicity is frustrated 
phagocytosis,
98,99
 which leads to overproduction of ROS by activated NADPH 
oxidases in phagosomes.
99,100 
This has been shown to be important in such conditions 
as asbestosis.
98
 Nanoparticles can also cause toxicity by leaching of transition 
metals,
101
 or by catalytic reduction of oxygen to O2
·-







However, gold nanoparticles are used extensively in biology and medicine.
103
 It 
would, therefore, be reasonable to expect the NS used in this work to have different 
toxicological characteristics from the nanomaterials described above. Since the 
ultimate goal of this work is to monitor IRP changes in cells, it was highly important 
to establish that nanosensor introduction did not induce any cellular toxicity or 
changes in IRP. 
 
In this chapter, results are presented on investigations into targeted cellular delivery 
of nanosensors and their cytotoxic effects.      
 
4.2 Cytosolic Nanosensor Delivery 
 
The uptake of NQ-NS and HQ-NS by cells in CS-free media was investigated using 
TEM. This is a type of high resolution microscopy, in which a beam of electrons is 
passed through ultra-thin samples. Images are then formed from the interactions of 
the electrons transmitted through the specimen and captured on photographic film, or 
more commonly nowadays, with a digital camera.
104
 TEM is an excellent imaging 
technique for examining nanosensor localisation because cells can be resolved at the 
organelle level and gold nanoparticles appear well contrasted against the cell due to 
their relatively high electron density
.105,106  
 
Figure 4.2 below shows that, under these culture conditions, nanosensors were taken 
up by cells into the cytoplasm. The TEM images in figure 4.2 also revealed that the 
nanosensors were neither encapsulated nor coated with lipids. Further TEM images 











Figure 4.2: TEM images of nanosensors in cells. The top image shows nanosensors 
(dark spots) in the cytoplasm beside rough ER. The bottom image shows nanosensors 
in the cytoplasm just outside the nucleus. Scale bars in white on the images. 
 
Figure 4.2 demonstrates that, with the correct delivery conditions, modified NS can 
be controllably delivered to the cytoplasm, where they reside freely. Importantly, it 
also demonstrates their potential utility in sensing cytoplasmic RPs. 
 
4.3 Nuclear Nanoparticle Delivery 
 
As outlined in chapter 1, RP varies from organelle to organelle.
6,8
 With gold 
nanoparticles, significant scope exists for targeting organelles, other than the 




Nuclear localisation sequences (NLSs) were first discovered in the large viral protein 
T-antigen, encoded by the SV40 virus.
110
 This particular NLS comprises a highly 






 The second 
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lysine residue Lys-128 is an absolute requirement for nuclear localisation, with the 
surrounding AAs being less specific.
110
 Since the discovery of this NLS in 1984, 








Figure 4.3: Mechanism of NLS import whereby an NLS sequence is recognised by 
importins and then taken into the nucleus across the nuclear pore complex with its 
cargo. 
 
In the cytoplasm, NLSs are recognised by importins and form a complex that is 
localised to the nuclear envelope and then translocated through the nuclear pores in 
an ATP-dependent process.
113
 Once inside the nucleus, the complex is degraded and 




Recently, several groups have shown that NR functionalised with a NLS can be 





In these experiments, two novel NLSs (CA-NLS 1 and CA-NLS 2), based on the 
SV40 NLS (PKKKRKV), were synthesised via solid-phase peptide synthesis (SPPS) 
and assembled on NR. NR were used, due to the fact that the NS used in the previous 
work were too large to cross the nuclear pore complexes (NPCs). NPCs are ~120 nm 
in diameter
114
 and thus too small to allow the NS (150 nm in diameter) to cross from 
the cytoplasm into the nucleus. NR on the other hand are only 10 × 38 nm in size 
and, when functionalised with NLS peptides, should be able cross the nuclear 
envelope through NPCs. Like NS, the NR also had a plasmon resonance close to 





4.3.1 Solid-Phase NLS Peptide Synthesis  
 
Pioneered by Merrifield in the 1960s,
117
 SPPS proved to be something of a 
revolution in bio-organic chemistry. SPPS involves the construction of AA 
sequences on linker molecules attached to insoluble support resins.
117
 Once 
assembled, the desired AA sequence can be cleaved from the support, using e.g. HF 
or TFA (preferable).
117
 SPPS offers significant advantages over peptide syntheses 
performed in solution, including: higher coupling efficiencies, simpler purifications 




CA-NLS 1 and CA-NLS 2 were both sequenced on aminomethyl polystyrene resin, 
functionalised with rink amide linker (labile under mild acidic conditions), using an 
Fmoc protecting group strategy. A key advantage of the Fmoc protecting group is 
orthogonality.
117
 It is a base labile protecting group. Reactive AA side chains can, 
therefore, be protected with acid-labile protecting groups, which are removed and 




In the synthesis of CA-NLS 1, DIC was used to activate carboxyl groups of incoming 
AAs to ensure faster, more efficient couplings, whereas HBTU was used for this 
purpose in the synthesis of CA-NLS 2. Mechanisms for AA couplings, Fmoc 
deprotection and peptide cleavage from the resin are shown in appendix 4.  
86 
 




Figure 4.4: Molecular structures of (A) CA-NLS 1 and (B) CA-NLS 2. NLS is 
highlighted in blue, spacer groups are highlighted in black, cysteine residues are 
highlighted in red and fluorescein is highlighted in green. 
 
Both CA-NLS 1 and CA-NLS 2 had the PKKKRKV NLS, in order to allow NR 
penetration of the nuclear membrane, spacer groups and cysteine residues, which 
permitted chemisorption to NR through their thiol moieties. CA-NLS 1 was also 
designed to incorporate fluorescein to allow intracellular detection of NR with 







4.3.2 Characterisation of NLS Functionalised NR  
 
The absorption spectra of NR, functionalised with both CA-NLS 1 and CA-NLS 2, 
displayed red-shifts, slight broadening of peaks and a dampening of peak intensity, 
compared to cetyltrimethylammonium bromide (CTAB)-coated NR.
108,118
 These 
























Figure 4.5: Absorption spectra of CTAB-NR (blue line), CA-NLS 1-NR (green line) 
and CA-NLS 2 (red line). A red-shift, peak broadening and dampening of peak 
absorbance is noted as NR are functionalised with NLS peptides. 
 

























Figure 4.6: SERS spectra of bare NR, CA-NLS 1-NR and CA-NLS 2-NR. 
 
Figure 4.6 shows a comparison of the SERS spectra from CTAB-capped NR and 
those functionalised with CA-NLS 1 and CA-NLS 2. It was observed that NLS 
functionalised NR showed some overlapping signals from the CTAB molecules. 







 Tables 4.1 and 4.2 below provide tentative assignments of 







Wavenumber (cm-1) Assignment  
1577 Amide stretching 
1445 AA C-H bending overlapping with CTAB CH2 bending 
1301 Lysine CH2 wagging  
1232 Arginine CH2 wagging 
1132 Xanthene ring vibrations 
1062 Proline C-N stretching 
968 C-C aliphatic vibrations  
758 AA COO
- 
deformation overlapping with CTAB C-N 
stretching 
 
Table 4.1: Vibrational assignments of CA-NLS 1. Assignments were made 
according to the literature. 
 
Peak Position (cm-1) Assignment  
1583 Amide stretching 
1446 AA C-H bending overlapping with CTAB CH2 bending 
1344 Glycine CH2 wagging 
1300 Lysine CH2 wagging 
1245 Arginine CH2 wagging 
1066 Proline/glycine C-N stretching 
761 AA COO
- 
deformation overlapping with CTAB C-N 
stretching  
 
Table 4.2: Vibrational assignments of CA-NLS 2. Assignments were made 








4.3.3 Fluorescence Imaging of NLS Functionalised NR in Nuclei 
 
NR functionalised with CA-NLS 1 were introduced into cells using the same CS-free 
culture conditions for the cytoplasmic delivery of NQ-NS and HQ-NS. Fluorescence 
microscopy was used to investigate successful delivery of NR into the nuclei of cells.  
 
In these experiments, nuclei were stained with Höescht dye, which binds to DNA and 
emits blue fluorescent light around 460 nm when excited by UV light.
122
 Using a 
digital camera and an appropriate light filter, images of cell populations were then 
recorded and locations of nuclei determined according to the blue fluorescent light 

















Figure 4.7: Fluorescence image of cells incubated with Höescht dye. Nuclei appear 
bright blue. 
 
When excited by UV light, the fluorescein moiety possessed by CA-NLS 1 emitted 
green light around 520 nm.
105
 As with the Höescht visualisation of cell nuclei, a 
digital camera and appropriate light filter were used to determine intracellular 





Figure 4.8: Fluorescence image of cells incubated with CA-NLS 1-NR dye. 
Presence of CA-NLS 1-NR indicated by bright green light emitted from fluorescein 
moiety. 
 
When the images in figures 4.7 and 4.8 are superimposed, there were clearly 
significant overlapping regions of blue and green fluorescent light (figure 4.9). The 
co-localisation of green light emitted from the fluoresceins of CA-NLS 1-NR with 
the blue light emitted from the Höescht dye (a well established DNA stain) clearly 




Figure 4.9: Overlay of figures 4.7 and 4.8. Turquoise areas indicate co-localisation 




It can be seen from figure 4.9 that there are multiple regions of overlap between 
figures 4.7 and 4.8 where CA-NLS 1-NR have successfully transfected the nucleus. 
There are also regions where the NR appear to be residing in the cytoplasm (i.e. 
green light emitted from the fluorescein is not overlapped by the blue light of 
Höescht dye).  
 
4.3.4 TEM Imaging of Functionalised NR in Nuclei 
 
For further confirmation of nuclear delivery of NLS functionalised NR, TEM images 
were obtained from cells which had been incubated with CA-NLS 2-NR in a pilot 
study. 
 
As with the fluorescence imaging experiments, TEM indicated successful 








Figure 4.10: TEM of CA-NLS 2-NR (dark rod shapes) in nucleus. Nuclear 
membrane, nucleus and cytoplasm indicated by arrow in the image. Scale bar = 200 
nm.  
 
The TEM study did, however, present several images of CA-NLS 2-NR that 









Figure 4.11: TEM of CA-NLS 2-NR trapped in vesicle outside nucleus. 
Encapsulated CA-NLS 2-NR indicated by arrow in the image. Scale bar = 500 nm. 
 
This suggests that, for more efficient nuclear transfection of nanomaterials, it may be 





4.4 Nanosensor Toxicity Study 
 
To determine whether or not nanosensor introduction resulted in any cytotoxicity, or 
initiating processes known to be accompanied by a change in IRP, several standard 
cellular assays were employed. ROS generation, apoptosis, cell viability and cellular 
glutathione status were all investigated.  
 
4.4.1 DCFH-DA Assay of Oxidative Stress 
 
The DCFH-DA assay is a well established technique for identifying any increase or 
accumulation of ROS in cells.
124,125






Figure 4.12: DCFH-DA mechanism of action. Non-fluorescent DCFH-DA is taken 
up by cells where it is enzymatically converted to DCFH. If excess ROS are present 




The membrane-permeable, non-fluorescent DCFH-DA is introduced into cells, 
where it is deacetylated by cellular esterase enzymes to 2’,7’-dichlorfluorescein 
(DCFH) (which is also non-fluorescent).
126
 The generation of ROS is then detected 




This assay was carried out on cells which had been incubated with functionalised NS 
in CS-free media for 5 h. Untreated cells (-ve control) and cells which had been 





 were also assayed for comparison. Results shown below, in figure 













































Figure 4.13: DCFH-DA assay results which show that nanosensor introduction does 
not result in any cellular oxidative changes. Untreated cells (blue bar), cells 
incubated with nanosensors (green bar), Zn +ve control (black bar) and tBOOH +ve 
control (red bar). 
 
Results from the DCFH-DA assay clearly show that, while, as expected, Zn and 
tBOOH induced a strong oxidative change in the cells, NS did not induce any 
detectable oxidative changes over a 24 h time period (figure 4.13). The result of this 
assay confirmed that modified NS do not themselves induce formation of ROS in 
cells. 
 
4.4.2 APOPercentage Assay 
 
A standard assay of apoptosis, the APOPercentage assay, was used, in order to 
determine whether or not the introduction of nanosensors into cells was causing them 
to undergo programmed cell death. Progression of the apoptotic pathway is well 







Figure 4.14: APOPercentage mechanism of action. Flippase enzyme ceases to 
maintain the asymmetric phospholipids bilayer and APOP% dye is taken up by cells 




Mammalian cell membranes are asymmetric phospholipids bilayers.
17
 In order to 
ensure cell viability, it is crucial that membrane structure is not distorted in any way. 
An enzyme known as flippase helps cells to maintain an asymmetric phospholipid 
bilayer.
130
 However, in apoptotic cells, flippase regulation is either overwhelmed, or 




In the APOPercentage assay, the APOP% dye is taken up by apoptotic-committed 
cells that have undergone membrane scrambling as shown in figure 4.14.
130
 
Following transmembrane movement, the APOP% dye enters the cell and continues 
97 
 
to do so until blebbing occurs.
130
 Once taken up by apoptotic cells, the APOP% dye 




This assay was applied to cells incubated with nanosensors to ascertain whether or 
not their introduction was resulting in apoptosis. Untreated cells were also assayed 
for comparison. Cells treated with staurosporine (1 μM), a compound known to 
induce apoptosis,
131
 were assayed as a positive control. Fluorescence intensities were 
normalised and reported as a percentage against the positive staurosporine control 
(figure 4.15).   



























Figure 4.15: APOPercentage assay results. While there is a clear increase in the % 
RFU of staurosporine treated cells vs. untreated cells, little difference is seen in the 
% RFU between the untreated cells and those treated with nanosensors. This 
indicates that the nanosensors are not inducing apoptosis. 
 
As can be seen from figure 4.15, the % RFU of staurosporine for the untreated cells 
and those treated with nanosensors were both relatively low and comparable. The 
indication from this assay was that nanosensor introduction did not result in 




4.4.3 MTT Assay 
 
The MTT assay is a standard colorimetric assay, used to assess cell proliferation and 
viability, i.e. lack of cytotoxicity. MTT is a yellow tetrazole and, in healthy cells, is 






Figure 4.16: MTT reaction in healthy cells. MTT (yellow) is reduced in healthy cells 
by mitochondrial reductase enzymes to form formazan crystals (purple). 
 
A solubilisation solution is added, to dissolve the insoluble purple formazan product 
into a coloured solution.
133
 Absorbance values are then read spectrophotometrically 
at 570 nm and cell viability is calculated according to equation 2.2 (page 41).  
 






































Figure 4.17: Cell viability determined from the MTT assay. Little difference is 
observed in the absorbance of untreated cells vs. those treated with nanosensors. This 
indicates that the nanosensors are not affecting cell viability. 
 
The calculated cellular viability from the absorbance values was 103 ± 22% for NQ-
NS treated cells. These results indicated no significant stimulation or inhibition of 
cell viability or growth, as a result of nanosensor introduction. That is, no cytotoxic 
effects were observed through the MTT assay.  
 
4.4.4 GSH-Recycling Assay 
 
As outlined in the introduction, the GSH-recycling assay is a well established 
indicator of cellular redox status.
47
 According to the [GSH]:[GSSG] ratio, an 
estimate of IRP can be made with the Nernst equation.
6
 This assay was used to 
determine whether or not the nanosensors used in this work were perturbing the 
[GSH]:[GSSG] ratio and thus affecting the IRP.  
 
Total GSH and GSSG levels of untreated cells and those treated with nanosensors 
were determined in triplicate from standard curves (appendix 7) and quoted in μM 
against the total protein content of the cells, as reported by the BCA protein assay (a 
100 
 
colorimetric technique, in which protein concentrations of cell populations are 
quantified through changes in absorbance). Total protein content was also 
determined from a standard curve but was expressed in mg (appendix 7).  
 
Total GSH levels were found to be 0.295 and 0.264 μM/mg for untreated and 
nanosensor-treated cells respectively. GSSG levels were found to be 0.0095 and 
0.0074 μM/mg for untreated and nanosensor treated cells respectively. These results 
showed no significant difference in GSSG percentage between untreated cells (3.1%) 
and nanosensor-treated cells (2.8%). This confirms that the redox state of the cell 




In this chapter it has been shown that SERS-active redox nanosensors can be 
selectively delivered to the cytoplasm of mammalian cells. Furthermore, through 
careful tuning of nanoparticle surface chemistry, an exciting opportunity to facilitate 
their access to other organelles has been presented. Monitoring redox poise in 
organelles such as the nucleus or mitochondria would enhance our understanding of 
oxidative stress.  
 
While it has previously been demonstrated that nanomaterials such as TiO2 fibres and 
carbon nanotubes can cause toxicity to cells,
96,97,98
 gold nanoparticles have been used 
extensively in biology and in the medical field.
99
 Importantly, in this work, it has 
been demonstrated that introduction of these nanosensors does not promote any 
cytotoxic events associated with oxidative stress such as ROS generation, apoptosis 
or necrosis. It has also been demonstrated that the cellular [GSH]:[GSSG] ratio is 






Measuring and Monitoring Intracellular 





In chapter 3, the possibility to quantify changes in RP rapidly and reversibly with 
SERS nanosensors was demonstrated. It was also shown, in chapter 4, that these 
sensors can be controllably delivered into cells without causing any cytotoxic side- 
effects. With the fundamentals for an ideal redox-monitoring system in place, the 
biological efficacy of the nanosensors in measuring and monitoring IRPs was 
investigated. 
 
In recent years, Raman spectroscopy has emerged as a very useful cellular-imaging 
technique. Through confocal Raman mapping, Uzunbajakava et al have 
demonstrated the possibility of charting DNA, RNA and protein distribution in 
apoptotic cells.
134
 The ability to use information-rich vibrational spectroscopy, in a 
non-invasive manner, to elucidate physiological processes is exciting and emphasises 
the potential of Raman spectroscopy to further our understanding of the complex 
biological processes which define cells.  
 
Raman mapping has even been used to study cellular response to drug treatments. 
Using a single cell, Draux et al were able to exploit the specificity and sensitivity of 
Raman mapping to changes in biomolecule structure, in order to investigate the 
effects on Calu-1 cells of gemcitabine (a chemotherapeutic drug used in the 
treatment of lung cancer).
135
 Through principal component analysis (PCA) of Raman 





 The work of Draux et al serves as an example of how Raman 
spectroscopy, specifically Raman mapping, can obtain useful clinical information 
from cells, which could have an impact on diagnostics and patient treatments.  
 
Coherent anti-Stokes Raman spectroscopy (CARS) is a variant of Raman 
spectroscopy that has similarly been used to probe cellular environments. CARS is a 
type of nonlinear Raman spectroscopy that offers users similar chemical information 
to that of regular Raman spectroscopy.
61
 By its nature, CARS makes it is possible to 





In February 2011, Pezacki et al published a review detailing the use of CARS in live 
cell imaging.
136
 The review highlights, particularly, the utility of CARS in studying 
lipids, without any perturbation to live cells.
136
 Through lipid studies with CARS, 
important information can be obtained on cellular metabolism, which may further 
our understanding of disease states including obesity, diabetes, cardiovascular 




Importantly for this work, SERS has also been shown as an excellent technique for 
cell imaging and bio-sensing.
137,138,139 
Detection of disease states and viruses, using 
tagged nanoparticles and SERS, is well documented.
66,140
  The ability to detect 
changes in intracellular environmental factors, notably pH, has also been confirmed, 




The precedents set in these studies meant that the nanosensors developed in this work 
were expected to perform as bio-sensors for redox measurements. In doing so, they 
would allow the ultimate aims of the work to be achieved and RP could be monitored 






In this chapter, results are presented on normoxic cytoplasmic RP measurements, as 
well as the monitoring of cytoplasmic RPs in response to superphysiological 
reductive and oxidative stimuli. Furthermore, the abilities of the nanosensors to 
quantify changes in RP during apoptosis (induced by staurosporine and H2O2) and as 
























5.2 Measuring Homeostatic Cytoplasmic RPs  
 
Before any attempts were made to monitor changes in IRP with the nanosensors 
developed in this work, it was first necessary to monitor the resting/homeostatic IRP 
and to ensure that this remained constant over an extended period. It would be 
reasonable to expect that the homeostatic IRP would be similar to those already 
reported as the nanosensors did not induce any cytotoxicity when introduced into 
cells. 
 
Cytoplasmic potentials in live cells were measured using both NQ-NS and HQ-NS. 
As expected, HQ-NS is fully reduced under conditions of normal cellular physiology 
(figure 5.1) and can, therefore, be considered insensitive in this potential window.  
 
Figure 5.1: HQ-NS as a normoxic cytoplasmic RP sensor. When fully reduced no 
peak is visible at 356 cm
-1
 and therefore resting cellular potential cannot be 
accurately estimated using HQ-NS. SERS spectra of HQ-NS from single cells 
display no noticeable variation over a 40 min period. 
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Raman Shift (cm
-1






Figure 5.2 shows the measured potential of NQ-NS over a 40 min period and 
confirms that the potential is not only invariant while making measurements over this 































Figure 5.2: NQ-NS as a normoxic cytoplasmic RP sensor. Potential calculated from 
the 1577/1645 cm
-1
 peak ratio. Error bars indicate the standard deviation of 
measurements taken during three independent experiments from single cells.  
 
At resting cellular potential, however, NQ-NS is approximately 36% reduced. This 
corresponds to a potential of -290 mV vs. NHE and is in good agreement with 
previously reported cytosolic potentials, which range from -315 to -280 mV vs. 
NHE.
6,50
 This also serves to once again highlight that the nanosensors are non-toxic 










5.3 Monitoring Oxidative Stress 
 
Since HQ-NS is sensitive to higher potentials outside those found under normoxic 
conditions, its utility was investigated under conditions known to cause oxidative 
stress in the cell. Oxidative stress was induced with AAPH (30 mM) – a membrane- 
permeable, free radical initiator, which generates a variety of ROS species, including 
O2
·-































Figure 5.3: HQ-NS as a sensor of oxidative stress caused by AAPH. calculated from 
the 477/356 cm
-1
 peak ratio. Error bars indicate the standard deviation of 
measurements taken during three independent experiments. 
 
From figure 5.3 it can be seen that only 6 mins after cells were exposed to AAPH, 
there is a measurable change in the cytoplasmic RP. The measured potentials are 
significantly more oxidative than those within the redox buffering range of the GSH 
system, indicating that this degree of oxidative stress cannot be dealt with by the 
cell’s natural antioxidant system. Generation of O2
·-
 by AAPH and its subsequent 











 It is, therefore, likely that the rapid formation of H2O2 leads to 
complete oxidation of cellular glutathione, resulting in a fast change in IRP, as 
observed here. 
 
5.4 Sequential Monitoring of Reductive and Oxidative 
Changes in Intracellular Redox Potential 
 
In order to maximize the potential range over which we can monitor, we combined 
the reductive sensitivity of NQ-NS with the oxidative sensitivity of HQ-NS and 
carried out a series of measurements under both oxidative and reductive stress. The 
combination of NQ-NS and HQ-NS means that the cytoplasmic potential can be 
monitored across a total of 450 mV, a previously unattainable range in a rapid and 
reversible manner with a gap of ca. 200 mV between the two sensors (figure 5.4). 
This functional range encompasses the hypoxic conditions in which tumours reside 
in order to avoid cell death mechanisms at one extreme and the oxidative conditions 
which are associated with a variety of inflammatory and degenerative disorders and 
ultimately cell death at the other. For comparison, roGFP can monitor from 
approximately −325 to −195 mV. REF 
 
The cytoplasmic potential was monitored over 40 min using both NQ- and HQ-NS in 
tandem. During this period DTT and AAPH were added to the cell’s media 
(indicated on figure 5.4) and changes in the ratios of the peaks at 1577/1645 and 
356/477 cm
-1
























































Raman Shift (cm-1) Raman Shift (cm-1)
 
 
Figure 5.4: IRP measurements during the addition of DTT and AAPH. Potentials 
monitored by these two sensors are represented as red circles. White squares 
represent points in which NQ-NS is fully reduced and insensitive to further reductive 
changes. Blue squares represent points in which HQ-NS is fully oxidised and, 
therefore, insensitive to further oxidative changes. Representative spectra for sensors 




Upon addition of 1 mM DTT, a membrane-permeable, strong reducing agent,
143
 
reductive changes in the cell were measurable after only 1 min. After 4 mins the 
potential dropped from -267 to -314 mV (approaching the limit of NQ-NS reductive 
sensitivity). AAPH (added after 8 mins) induced an oxidative change in the cell, 
which were quantifiable through monitoring the SERS spectrum of NQ-NS. 
Oxidative changes were measurable at 13 mins and the cytoplasm became 
progressively more oxidative, to the extent that NQ-NS was fully oxidised (17 mins, 
RP = -208 mV), at which point further oxidative changes were monitored using HQ-
NS.  
 
The data from HQ-NS showed an increasingly oxidative environment and also an 
increased rate of oxidative change, which was to be expected, since this potential 
region was beyond the ‘redox buffering’ capacity of the GSH/GSSG pair. After 20 
mins, HQ-NS was fully oxidised, indicating that the potential was at least 250 mV 
vs. NHE, and it maintained that status throughout the remainder of the experiment.  
 
5.5 Monitoring Cytoplasmic RP during Apoptosis 
 
Apoptosis is the process of programmed cell death, which occurs in multicellular 
organisms.
17
 Unlike necrosis, apoptosis proceeds in a controlled and regulated 
fashion and, paradoxically, can prove advantageous for organisms.
17
 Typically, 
during apoptosis, caspase enzymes are activated.
144
 Caspases are a family of protease 
enzymes
145
 which can degrade essential cellular components, including structural 
proteins in the cytoskeleton and nuclear proteins such as DNA repair enzymes.
144 
Caspases can also activate enzymes such as DNases which cleave DNA in the 
nucleus.
146
 Compared to healthy dividing cells, apoptotic cells display a number of 
distinctive morphological differences. Cell shrinkage, rounding, blebbing, as well as 







Figure 5.5: Images of (A) healthy cells and (B) apoptotic cells.
147 
Apoptotic cells 
appear shrunken and more rounded than healthy cells. 
 
In cells, apoptosis can result from a variety of factors, including DNA damage, 
growth factor depletion, viral infection and excessive ROS generation. Apoptosis can 
proceed via several, different, mechanisms. It may progress with the involvement of 
the mitochondria, after being triggered by an internal signal.
148
 In this apoptotic 
pathway, Bcl-2 (a protein located on the surface of the mitochondrial membrane, 
which guards against apoptosis) is inhibited by Bax (a pro-apoptotic protein).
149
 
Upon inhibition of Bcl-2’s protective effects, the outer mitochondrial membrane is 
ruptured and cytochrome C leaks into the cytoplasm, where it binds apoptotic 
protease activating factor-1 (APAF-1) to form apoptosomes.
150
 Apoptosomes can go 
on to activate caspase-9.
151
 Caspase-9 can, in turn, activate caspases-3 and -7 
























Figure 5.6: Mitochondrial apoptotic pathway. Bcl-2 is inhibited by Bax resulting in 
cytochrome C release into the cytoplasm. This is followed by apoptosome formation, 
caspase activation and ultimately cell death.  
 
Apoptosis may also progress with the involvement of death receptors, after being 
triggered by an external signal. In this apoptotic pathway, the membrane proteins Fas 
and tumour necrosis factor (TNF)
153,154 
receptors bind their complementary death 
activators (FasL and TNF respectively). This leads to activation of caspase-8, which 




















Figure 5.7: Death receptor apoptotic pathway. Fas and TNS bind their 
complimentary death activators resulting in caspase activation and ultimately cell 
death. 
 
Not all apoptotic pathways are caspase-dependent. Apoptosis-inducing factor (AIF) 
is a mitochondrial protein, well known to cause cell death.
155
 When the cell receives 
an appropriate death signal, AIF is released from the mitochondria.
155
 AIF then 
migrates to the nucleus where it can bind to and degrade DNA, ultimately resulting 














Figure 5.8: AIF apoptotic pathway. AIF is released from the mitochondria and 











While the experiments detailed on pages 99-101 represent the utility of HQ-NS and 
NQ-NS in monitoring superphysiological stresses, NQ-NS has also been used to 
measure the oxidative changes which occur in cells as a result of apoptosis. Initially, 
apoptosis was induced with stauosporine, at a concentration of 1 μM. This was 
determined to be cytotoxic using an established apoptosis assay. Potential 
measurements were then made inside cells, as apoptosis was induced with H2O2 (a 
physiologically relevant oxidant).  
 
Staurosporine (figure 5.9) is a protein kinase inhibitor
156
 and is known to be a potent 
inducer of apoptosis.
157
 The mechanism(s) by which staurosporine induces apoptosis 
is still a matter of debate in the literature.
131,157
 While some reports show that caspase 
activation is required for staurosporine-induced apoptosis, mechanisms independent 





Figure 5.9: Molecular structure of staurosporine. 
 
Figure 5.10 demonstrates that IRP became progressively more oxidative over the 6 h 

























Figure 5.10: Cytosolic potential measurements from cells undergoing staurosporine-
induced apoptosis. Blue circles represent potentials measured in untreated cells and 
red circles represent potentials measured in cells treated with staurosporine. Error 
bars represent the standard deviation across ten single-cell measurement. 
 
An increase in IRP of 70 mV was observed over the 6 h incubation period. A control 
population of cells, untreated with staurosporine, did not undergo statistically 
significant oxidative changes over the same period. These changes are in agreement 





As a signalling molecule, H2O2 is important as a trigger in a multitude of cellular 
pathways. One of those pathways is mitochondrial mediated apoptosis. In order to 
determine a suitable concentration of H2O2 to induce apoptosis in cells, the 
APOPercentage assay was used once again (figure 5.11). Results shown below, in 



























Figure 5.11:  Results of the APOPercentage assay for cells incubated with 
increasing concentrations of H2O2. Error bars represent the standard deviation across 
four populations. 
 
Using the APOPercentage assay, 500 μM was determined to be a high enough 
concentration of H2O2 to induce apoptosis. This concentration was in good 




Similar to staurosporine-induced apoptosis, oxidative changes were also observed 
with NQ-NS over a 7 h period (figure 5.13) in cells where apoptosis had been 
induced with H2O2 (500 μM). These findings were further supported by results from 
cells treated with H2O2 (500 μM) and assayed with the APO-One assay (figure 5.13).  
 
The APO-One assay is a fluorescence assay which measures a given sample’s 
caspase-3/7 activity.
159
 In this particular assay, Apo-ONE homogeneous caspase-3/7 
buffer (which efficiently lyses/permeabilises cultured mammalian cells) is mixed 
with the caspase-3/7 substrate rhodamine 110, bis-(N-CBZL- aspartyl-L-glutamyl-L-
116 
 
valyl-L-aspartic acid amide; Z-DEVD-R110) (which exists as a pro-fluorescent 
substrate prior to the assay).
159
 Upon cleavage and removal of the DEVD peptides by 
caspase-3/7 activity and excitation at 499 nm, the rhodamine 110 leaving group 







Figure 5.12: Cleavage of the DEVD groups from non-fluorescent caspase substrate 
Z-DEVD-R110 by caspase-3/7 to yield fluorescent Rhodamine 110. 
Excitation/emission of Rhodamine 110 is at 499/521 nm. 
 


























































Figure 5.13: Intracellular potential measurements and caspase activity from cells 
undergoing H2O2 induced apoptosis. Diamonds represent potential measurements, 
and columns represent measurements of caspase 3/7 activity. Error bars in potential 
measurements represent the standard deviation across 10 single-cell measurements, 
and error bars in caspase activity represent standard deviation across 10 replicate 
wells.  
 
Figure 5.13 shows that, with the NQ-NS, an increase in IRP of 68 mV can be 
observed over the 7 h incubation period. A control population of cells, untreated with 
H2O2, did not undergo statistically significant oxidative changes over the same 
period. Attempts were made to measure the RP in cells incubated with H2O2 after 10 
h. At this time, however, the vast majority of cells in the population were either dead 
or detached from the coverslip on which they were grown.  
 
Figure 5.13 also shows the caspase-3/7 activity of H2O2 treated cells compared to 
untreated cells over a 10 h time course. Caspase-3/7 activity increased over the first 7 
h. After 10 h, a drop in caspase activity was noted. This may be due to oxidation of 
the caspase enzymes. Both caspase-3 and caspase-7 are cysteine proteases and, 
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therefore, contain cysteine residues in their active sites.
145
 As RP increases over time, 
so does cysteine oxidation in the active sites of caspase-3 and caspase-7, reducing 
their activity and thus reducing the fluorescence signal observed from the APO-One 
assay. Results shown in figure 5.13 were obtained in collaboration with V. 
Mallikarjun (University of Edinburgh). 
 
These measured changes in redox potential are in agreement with measurements of 
apoptotic potentials made using an assay based on measurement of glutathione 
oxidation.
129
 The data in demonstrate the correlation between redox potential, 
protease activity, and cellular phenotype and underline the critical interplay between 
redox potential and physiological processes. 
 
5.6 miR-199a-3p and Oxidative Stress Regulation 
 
miRNAs are short (~22 nucleotide) ribonucleic acid (RNA) sequences.
160
 In animals, 
genes for miRNAs are first transcribed to primary miRNA (pri-miRNA).
160
 pri- 
miRNAs are processed in the nucleus to precursor miRNA (pre-miRNA) by Drosha 
(a class 2 RNase III enzyme).
160
 Pre-miRNAs are then transported into the cytoplasm 
in a process mediated by exportin-5 (EXP-5).
160
 In the cytoplasm, pre mi-RNAs are 
matured through further processing by Dicer (also an RNase III enzyme). Following 
maturation, miRNAs are loaded onto Argonaute (AGO) proteins, leading to 
formation of the effector RNA-induced silencing complexes (RISCs).
160
 Figure 5.14 





















Figure 5.14: miRNA synthesis in animals. Pri-miRNAs are transcribed from genes 
before being processed to pre-miRNA by Drosha. Pre-miRNAs are then transported 
to the cytoplasm (by EXP-5) where Dicer helps them to mature before they form 
effector RISC complexes with AGO proteins.     
 
miRNAs act as post-transcription regulators that bind to specific messenger RNAs 
(mRNAs), and usually cause suppression of translation, degradation of targets or 
gene silencing.
160
 In animal cells, miRNAs target the non-coding three prime 
untranslated regions (3'UTR) of a given mRNA. miRNAs need not be fully 
complementary with their target mRNA, they may target different sites on the same 













Translation Suppression / Target Degradation
 
 
Figure 5.15: miRNA mechanism of action.  RISC bind to the 3’ UTR of target 
mRNAs to facilitate their suppression/degradation. 
 
In 2010, Santhakumar et al identified that miR-199a-3p plays a regulatory role in the 
NRF2-mediated oxidative stress pathway.
161
 NRF2 is a transcription factor that 
induces production of antioxidant enzymes including GSTs and NADPH quinone 
oxidoreductase 1 (Nqo1).
162,163
 Since the NRF2 pathway is so closely implicated in 
the cell’s response to oxidative stress, it would be reasonable to speculate that any 
down-regulation of these genes by miR-199a-3p would be accompanied by oxidative 
changes. 
 
Using NQ-NS, the cytosolic potential was measured inside cells transfected with 




































    
 
Figure 5.16: Box and whisker plot showing RP measurements of population of cells 
treated with a miR-199. Negative control cells were treated with non-targeting miR-
67 from C. Elegans. Error bars represent the standard deviation of 15 measurements. 
 
Figure 5.16 shows that cells treated with miR-199a-3p appeared to have had their 
cytoplasmic potential increased by 19 mV compared to untreated cells. No 
statistically significant variation in potential was observed between the untreated 
cells and those treated with C. elegans miR-67 negative mimic (employed as a 
control miRNA). It can also be seen from figure 5.16 that there was quite a large 
variation in the potentials measured from cells treated with miR-199a-3p. They 
ranged from -278 to -204 mV. This large variation may be due to the transfection 
process being non-uniform, i.e. some cells take up several copies of miRNA mimic 
whereas other take up none, something that has been observed in our collaborator’s 
miRNA transfection studies. Overall, however, the measurements revealed an 
oxidative increase in potential indicating that miR-199a-3p may indeed play an 
important regulatory role in the NRF2-mediated oxidative stress pathway. Results in 






While the use of Raman spectroscopy and its variants are well known in cellular 
imaging, it has never before been used to quantitatively monitor changes in IRP. The 
nanosensors developed in this work, have made it possible to quantitatively monitor 
changes in IRP. Reversible changes in IRP were recorded in real-time as cells 
responded to superphysiological reductive (DTT) and oxidative (AAPH) stimuli. 
Additionally, changes in IRP were monitored as cells underwent apoptosis (induced 
by both staurosporine and H2O2), as well as during miRNA transcription regulation 
of the NRF2-mediated oxidative stress pathway. As miRNAs emerge as potential 
therapeutic agents, their regulation of IRP may be interesting when developing new 
drug targets for disease states, such as cancer or neurological disorders. These 
sensors have been demonstrated as a novel and exciting tool with which to monitor 






Conclusions and Future Work 
 
The overall aims of this work were to develop SERS-active nanosensors capable of: 
 
 Quantitatively and reversibly monitoring changes in IRP with optimal 
spatiotemporal resolution. 
 Demonstrating potential for monitoring RP at a sub-cellular level. 
 Monitoring IRP from hypoxia through oxidative stress. 
 
Today, when calculating IRP, most researchers still use Tietze’s assay.
47
 However, 
this is far from ideal. Although cheap and simple to use, its requirement for cell lysis 
excludes its use in IRP monitoring. Furthermore, it cannot account for intracellular, 
or even intercellular, variation. Instead, it is used to calculate the ‘global’ potential of 
thousands of cells in a given population. Even at the cutting edge of redox 
measurements, using roGFPs, there are significant drawbacks. These sensors, while 
usable in live monitoring,
12
 operate in a narrow potential window which has little 
scope for extension. As they are fluorescent, they require cells to be excited in the 





In this thesis, a novel approach to IRP measurements, offering significant advantages 
over established techniques and the current state of the art, has been presented. Small 
molecule sensors have been developed and characterised. Crucially, these sensors 
displayed changes in their SERS spectra which were dependent on their oxidation 
state. These changes were quantifiable according to the Nernst equation and optical 
signatures of the nanosensors were shown to correlate well with those predicted by 




Through TEM, it has been shown that, with the right culture conditions, nanosensors 
can be selectively delivered to the cytoplasm. Two novel NLS peptides were 
synthesised and, with them, it was shown that NR could be selectively delivered into 
cell nuclei. This highlighted the fact that, through tuning of particle size and surface 
chemistry, considerable scope exists to access other organelles. Monitoring redox 
balance in compartments, such as the mitochondria or nucleus, would be highly 
advantageous in gaining an improved understanding of oxidative stress. For example, 
specific roles have been reported for mitochondrial oxidative stress in apoptosis,
5 
while nuclear oxidation can lead to the formation of the mutagenic oxidative DNA 
adduct 8-OHdeoxyguanosine.
164
 Redox imbalances in the ER have also been shown 
to trigger the unfolded protein response (UPR), a process which has been implicated 
in several disease states, including cardiovascular disease.
165
 Co-functionalisation of 
NR with a NLS peptide and sensor molecule may offer an opportunity to deliver 
functional nanosensors to cell nuclei. The NLS, while allowing particles to transfect 
nuclei, would be expected to have a smaller Raman cross-section than the sensor 
molecules, which would hopefully allow their spectra to be sufficiently 
de-convoluted, in order to allow useful information pertaining to the nuclear RP to be 
obtained. 
 
When developing new bio-sensing modalities, it is important to establish that the act 
of making a measurement will not unduly perturb the system. To this end, it has been 
shown, using a variety of assays, that the nanosensors used in this work were non-
toxic and, upon their introduction, cells remained viable and did not die. It has also 
been shown, using established independent assays of oxidative stress, that the 
nanosensors did not induce oxidative changes. Results of these assays were further 
supported by spectroscopic measurements revealing that IRP was invariant 
throughout a period of regular monitoring. The potential values obtained through 
SERS measurements were in good agreement with previous cytosolic potential 
measurements conducted under conditions of normal cell physiology.
6,50
 While 
nanomaterials, such as TiO2 fibres, fullerenes and carbon nanotubes, are known to 
cause toxicity in cells and animals,
96,97,98
 gold nanoparticles have been used 
extensively in biology and medicine.
103
 It is unsurprising, therefore, that the 
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nanosensors used in this work were similarly non-toxic and did not unduly perturb 
cellular systems.  
 
In terms of bio-functionality, the nanosensors performed well. They were able to 
monitor cytoplasmic potentials in a quantitative and reversible way, during both 
superphysiological stress events and throughout physiological processes. 
Importantly, they were able to do so in real-time and over a previously unattainable 
potential range.  
 
While the potential window covered by these sensors is significantly larger than that 
covered by fluorescent proteins, there is a need for further sensors which cover the 
region between NQ and HQ (from -200 to -50 mV vs. NHE). The ability to measure 
and monitor potentials accurately in this region could prove valuable in the study of 
diseases such as cardiovascular disease, neurodegenerative conditions and chronic 
inflammation, where oxidative stress is known to ensue.
24,31,32
 In this regard, a 
substantial advantage of using small molecules, rather than proteins, is that their 
standard potentials can be tuned relatively easily and predictably, using standard 
synthetic modifications. 
 
Overall, it can be said that the aims of the research have been met. The nanosensors 
developed here represent a new and noteworthy bio-analytical tool. In conjunction 
with proteomic studies, the measurements possible with them can be used to gain a 
fuller understanding of redox biochemistry. They offer users several key advantages 
over established techniques and current practice. Most notable are their abilities to 
monitor IRP quantitatively, reversibly and over a wider potential range than ever 
before, without system perturbation. With the approach detailed here, significant 
capacity now exists to target nanosenors at organelles, in order to make original RP 
measurements that can further our understanding of the multitude of 





In terms of the future direction of the research, there are many exciting challenges 
and possibilities to be explored. Below is a list of key issues which should be 
addressed: 
 
(1) Development of a sensor which monitors IRP from -200 to -50 mV vs. NHE - 
It should be possible to modify the aromatic ring of NQ-NS with electron 
withdrawing groups (e.g. NO2 or CN) using standard organic chemistry. This should 
make its E1/2 and indeed the potential range it can cover more oxidative. By 
developing a sensor which monitors IRP at a more oxidative poise than NQ-NS it 





(2) Measure/monitor the redox poise of the nucleus - Having successfully 
delivered NR into the nuclei of cells, the possibility of making a nuclear potential 
measurement should be explored. Co-functionalisation of NR with NLS peptides and 
sensor molecules should be attempted. It would be reasonable to expect that Raman 
signals from the probe molecules would be easily discernable as they would be 
expected to have greater Raman cross-sections. Concentrations of NLS peptides and 
probe molecules as well as incubation times in NR functionalisation would need to 
be thoroughly screened. Cellular delivery conditions and toxicity studies would again 
need to be carefully investigated for any such experiments.  
 
(3) Investigate the delivery of nanosensors into other organelles - As well as the 
nucleus, it would be interesting to explore the possibility of delivering nanosensors 
into other cellular compartments. The mitochondria would be an interesting target as 
it is here where much of a cell’s pivotal redox biochemistry happens.
2,17,
 It has 
recently been shown that cargos with PPh3 moieties can lead to their entry into the 
mitochondria.
166
 Tagging nanosensors with such functional groups may facilitate 
their delivery into the mitochondria. The ability to monitor redox changes in the 
mitochondria may provide a richer understanding of the fundamental redox process 




(4) Use AQ-NS to measure/monitor redox poise in hypoxic cells - The delivery 
of AQ-NS into hypoxic cells (such as cancer cells) should be attempted in similar 
conditions to those outlined in chapter 4. While AQ-NS has also been shown to 
undergo quantifiable changes in potential, it would be useful to explore its ability to 
measure and monitor IRP hypoxic cells (such as cancerous cells).
167
 If it should 
prove possible to use the AQ-NS sensor in such circumstances, this would potentially 
offer fresh and useful insights into tumour biology and its progression. 
 
(5) Development of an integrated vision of apoptotic redox control - By using the 
sensors developed here in conjunction with the Fourier transform mass spectrometry 
(FT-MS) facilities available at the University of Edinburgh; it should be possible to 
correlate changes in IRP during apoptosis with redox-related modifications to 
proteins involved in the core apoptotic pathway. This would enable the assembly of a 
comprehensive model of apoptosis where redox modifications of individual proteins 
could be predicted on the basis of their E
Θ
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Appendix 1a: AQ CV analyses including iRed/ iOx and CRed/ COx ratio and plot of iOx 
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Appendix 1b: NQ CV analyses including iRed/ iOx and CRed/ COx ratio and plot of iOx 
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Appendix 1c: HQ CV analyses including iRed/ iOx and CRed/ COx ratio and plot of iOx 































427 489 1.294 1.330 0.124 0.130 0.973 0.954 
 
 
























Appendix 1d: FCBX CV analyses including iRed/ iOx and CRed/ COx ratio and plot of 
iOx vs. scan rate. 
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Appendix 2: UV-vis spectra of RAM functionalised NS. Bare NS (black line), NQ-





















Appendix 3: TEM images of nanosensors. (A)  Single nanosensor; (B) nanosensor 
dimmer; (C) nanosensor trimer; (D) single cytoplasmic nanosensor adjacent to a 
mitochondrion; (E) single nanosensor in cytoplasm; (F) single nanosensor in 
cytoplasm; (G) nanosensor aggregate in cytoplasm and; (H) single nanosensor 
between two nuclei. Arrows have been used to identify nanosensor locations where 
resolution is low. 
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Appendix 4a: Molecular structure of AAs used in the syntheses of CA-NLS 1 and 






















































Appendix 5 Fluorescence Images of CA-NLS 1-NR 




Appendix 5a: Image set 1. Where: Top image = Höescht stained nuclei; middle 








Appendix 5b: Image set 2. Where: Top image = Höescht stained nuclei; middle 












Appendix 5c: Image set 3. Where: Top image = Höescht stained nuclei; middle 















Appendix 6: TEM images of: (A) Small cluster of NR; (B) large cluster of NR; (C) 






















Appendix 7 GSH Recycling Assay Standard Curves 
 
































































































Appendix 8 Representative SERS Spectra from 
Intracellular Experiments 
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Appendix 8a: SERS spectra of NQ-NS from cells undergoing staurosporine-induced 
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Appendix 8b: SERS spectra of NQ-NS from cells undergoing H2O2-induced 

























Appendix 8c: SERS spectra of NQ-NS from cells treated with miR-199 and C. 
Elegans miR-67, as well as untreated cells.  
 
